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Synaptic, Circuit, And Behavioral Insights Into Cdkl5 Deficiency Disorder
Abstract
Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5) gene cause a severe
neurodevelopmental disorder named CDKL5 deficiency disorder (CDD). In humans, CDD is characterized
by early-onset epilepsy, severe intellectual disability, autistic features, and various comorbidities. Mice
lacking functional CDKL5 protein show a constellation of behavioral deficits, including impaired learning
and memory, reduced sociability, and increased stereotypy, that are reminiscent of human symptoms.
Despite its simple genetic etiology, how the loss of CDKL5 leads to the unique symptomatology of CDD is
not well understood. Using genetically modified mouse models of CDD, we dissect the cellular origins of
behavioral, circuit, and synaptic phenotypes in CDD. We find that impaired learning and memory primarily
originates from CDKL5 loss in forebrain glutamatergic neurons, whereas autistic-like features primarily
originate from CDKL5 loss in forebrain GABAergic neurons. At the cellular and circuit level, loss of CDKL5
in glutamatergic neurons leads to altered pyramidal neuron morphology and concomitant changes in
excitatory and inhibitory synaptic transmission, resulting in disrupted spatiotemporal dynamics of
microcircuits. In contrast, loss of CDKL5 in GABAergic neurons leads to a non-cell autonomous change in
excitatory synaptic transmission and circuit hyperexcitability. Consistent with this finding, acute
pharmacologic reduction of glutamatergic synaptic signaling rescues selective phenotypes of CDD in
mice. Taken together, our results suggest that CDKL5 plays distinct roles in forebrain glutamatergic and
GABAergic neurons to regulate cellular morphology, synaptic function, and circuit excitability, and that
modulation of synaptic transmission provides a novel therapeutic avenue to treat CDD.
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ABSTRACT
SYNAPTIC, CIRCUIT, AND BEHAVIORAL INSIGHTS INTO CDKL5 DEFICIENCY DISORDER
Sheng Tang
Zhaolan (Joe) Zhou
Douglas A. Coulter

Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5) gene cause a severe
neurodevelopmental disorder named CDKL5 deficiency disorder (CDD). In humans, CDD is
characterized by early-onset epilepsy, severe intellectual disability, autistic features, and various
comorbidities. Mice lacking functional CDKL5 protein show a constellation of behavioral deficits,
including impaired learning and memory, reduced sociability, and increased stereotypy, that are
reminiscent of human symptoms. Despite its simple genetic etiology, how the loss of CDKL5
leads to the unique symptomatology of CDD is not well understood. Using genetically modified
mouse models of CDD, we dissect the cellular origins of behavioral, circuit, and synaptic
phenotypes in CDD. We find that impaired learning and memory primarily originates from CDKL5
loss in forebrain glutamatergic neurons, whereas autistic-like features primarily originate from
CDKL5 loss in forebrain GABAergic neurons. At the cellular and circuit level, loss of CDKL5 in
glutamatergic neurons leads to altered pyramidal neuron morphology and concomitant changes
in excitatory and inhibitory synaptic transmission, resulting in disrupted spatiotemporal dynamics
of microcircuits. In contrast, loss of CDKL5 in GABAergic neurons leads to a non-cell autonomous
change in excitatory synaptic transmission and circuit hyperexcitability. Consistent with this
finding, acute pharmacologic reduction of glutamatergic synaptic signaling rescues selective
phenotypes of CDD in mice. Taken together, our results suggest that CDKL5 plays distinct roles
in forebrain glutamatergic and GABAergic neurons to regulate cellular morphology, synaptic
function, and circuit excitability, and that modulation of synaptic transmission provides a novel
therapeutic avenue to treat CDD.
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CHAPTER 1 - INTRODUCTION

Overview
Since the first reports linking the X-linked cyclin-dependent kinase-like 5 (CDKL5)
gene to a severe childhood epileptic encephalopathy, CDKL5 deficiency disorder (CDD)
has come to be recognized as an independent clinical entity that has features distinct
from classic Rett syndrome and other neurodevelopmental disorders (Fehr et al., 2012;
Kalscheuer et al., 2003; Tao et al., 2004; Weaving et al., 2004). To date, at least several
hundred cases of CDD have been reported worldwide, with the majority of patients being
heterozygous females. Clinically, early-onset epilepsy is the most prominent feature of
CDD, with seizures persisting throughout life despite treatment. Developmental delay is
common, with most patients experiencing a range of comorbid symptoms that can
include motor dysfunction, intellectual disability, communication deficit, feeding and
gastrointestinal problems, sleep disturbance, and breathing abnormalities.
The establishment of mouse models of CDD has confirmed the importance of
this gene for proper brain development and neurologic function. In addition, they have
provided an in vivo setting to discover and validate various protein-protein interactions
and signaling pathways involving CDKL5 and test newly uncovered therapeutics.
Importantly, animal models represent an opportunity to address two unanswered
questions: 1) What are the most prominent phenotypes in mouse models of CDD at the
cellular, circuit, and behavioral levels, and 2) Do the behavior phenotypes arise from
shared or distinct cellular and circuit mechanisms?
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The Genetics and Clinical Features of CDKL5 Deficiency Disorder
To date, at least several hundred cases of CDD have been recorded, with the
incidence of the disorder estimated at 1/500,000 live births (Hector et al., 2017). Prior to
the identification of its genetic etiology, most cases of CDD bore other clinical diagnoses,
including atypical Rett syndrome, infantile spasms, West Syndrome, and LennoxGastaut Syndrome (Hanefeld, 1985; Mirzaa et al., 2013). In 2003, the clinical syndrome
was reported for the first time in association with genetic lesions in two patients
commonly disrupting CDKL5 (Kalscheuer et al., 2003). Subsequently, numerous studies
confirmed the existence of CDKL5 mutations in the Hanefeld variant of Rett syndrome
characterized by early-onset seizures (Evans et al., 2005; Mari et al., 2005; Scala et al.,
2005; Tao et al., 2004; Weaving et al., 2004), and the disorder came to be recognized as
an independent clinical entity (Fehr et al., 2012). The vast majority of patients are
females heterozygous for a mutation in CDKL5, although hemizygous male patients
have also been reported.
CDD typically arises from de novo mutations in the cyclin-dependent kinase-like
5 (CDKL5) gene, which resides in the distal portion of the short arm of the X
chromosome (Xp22). The gene was initially named serine-threonine kinase 9 (STK9)
upon first identification of the DNA sequence, but its protein sequence similarity to CDKL
family proteins led to its present name. CDD is distinguished from disorders that involve
duplications of CDKL5, of which a small number of cases have been reported. These
patients have features such as intellectual disability and autistic features, but typically do
not suffer from epilepsy (Szafranski et al., 2015).
The most prominent and disabling symptom of CDD is early-onset, treatmentresistant epilepsy (Bahi-Buisson et al., 2008). The prevalence of epilepsy in the disorder
2

is estimated to be more than 95% in both female and male patients, with the median age
of onset at 6 weeks (Bahi-Buisson et al., 2008; Fehr et al., 2016b). The epilepsy
associated with CDD is heterogeneous in both presentation and progression, but a
subset of patients has been described to involve three distinct stages (Bahi-Buisson et
al., 2008). Infantile spasms are common, accompanied by eventual development of
myoclonic and tonic-clonic seizures in many patients (Bahi-Buisson et al., 2008; Grosso
et al., 2007). Electrographic features such as slowing of background activity, focal and
multifocal discharges, and burst suppression have been reported, with significant
heterogeneity in presentation and progression of electroclinical features across case
studies (Klein et al., 2011; Melani et al., 2011). The long-term efficacy of anti-epileptic
drugs is low, with one study reporting a 12-month responder rate of 24% (Müller et al.,
2016).
Although seizures are typically the presenting symptom of CDD, patients suffer
from significant comorbidities, including profound intellectual disability, language deficit,
motor impairment, autonomous dysfunction, gastrointestinal issues, and sleep
disturbance (Bahi-Buisson et al., 2008; Fehr et al., 2016a; Mangatt et al., 2016).
Interestingly, male patients appear, on average, to have greater impairment of motor
function as compared to female patients (Fehr et al., 2016a). Patients with truncating
mutations outside the catalytic domain may have milder symptoms (Fehr et al., 2016b;
2015), but the establishment of clear genotype-phenotype correlations have been
hampered by the limited size of patient cohorts. In addition to the differential impact of
various mutations in CDKL5, random X-chromosome inactivation likely contributes to the
clinical heterogeneity in female patients (Hagebeuk et al., 2013; Weaving et al., 2004). In
order to better understand the clinical progression of CDD and its associated
3

comorbidities, at least one major international effort has been initiated to conduct a
coordinated natural history study.

CDKL5 Protein: Molecular Features and Expression Profiles
The CDKL5 protein is highly conserved among vertebrates, with 96% identity at
the amino acid level between the mouse and human orthologues of CDKL5. Nearly all
pathogenic missense mutations in patients cluster within the amino(N)-terminal kinase
domain of CDKL5, suggesting that perturbed kinase function likely underlies the
pathophysiology of the disorder (Hector et al., 2017).
The approximately 300-amino acid catalytic domain of CDKL5 bears significant
similarity to that of cyclin-dependent kinases (CDKs) in many organisms (Manning et al.,
2002). However, even among the CDKL family, CDKL5 is unique in possessing a long
carboxy(C)-terminal domain of about 700 amino acids, a feature that is conserved
across most mammalian species (UniProt Consortium, 2018; Zhu et al., 2013). Although
previous studies suggest that this C-terminal domain can serve as a negative regulator
of CDKL5 kinase activity and is capable of affecting protein sub-cellular localization
within heterologous cell lines (Lin et al., 2005; Rusconi et al., 2008), its in vivo function
remains unclear. In addition, the CDKL5 protein also encodes two putative nuclear
localization sequences (NLS) and a nuclear export sequence (NES) within this Cterminal region, suggested to serve in shuttling between the nucleus and cytoplasm
(Bertani et al., 2006). However, the limited availability of tools to visualize and tag
endogenous CDKL5 in vivo has made this result difficult to replicate. Several CDKL5interacting proteins have been identified, including AMPH1, DNMT1, NGL-1, PSD-95,
4

MIB1, and SHTN1 (Kameshita et al., 2008; Mertz et al., 2015; Nawaz et al., 2016;
Ricciardi et al., 2012; Sekiguchi et al., 2013; Zhu et al., 2013). However, the specific
cellular context and functional significance of these interactions remain unclear.
Although multiple CDKL5 isoforms have been identified, one major isoform is
highly enriched in the brains of humans, rats, and mice (Hector et al., 2016). Within the
brain, there is evidence that CDKL5 protein is expressed most highly in neurons of the
forebrain and at relatively low levels in glia (Kang et al., 2011; Wang et al., 2012; Zeisel
et al., 2015; Zhang et al., 2014). In addition to its localization in the nuclear and
cytoplasmic compartments (Rusconi et al., 2008), CDKL5 has been found, in multiple
studies, to also be localized at the postsynaptic density, sites of excitatory synapses
(Bayés et al., 2012; Reim et al., 2017; Ricciardi et al., 2012; Zhu et al., 2013). CDKL5
also follows an interesting temporal expression pattern, present at relatively low levels
embryonically and rising during early postnatal development (Hector et al., 2016).

Generation and Characterization of CDKL5-Deficient Mice
The high level of conservation of its sequence, expression pattern, and
localization motivated the generation of an animal model to study the in vivo functions of
CDKL5. The first Cdkl5 constitutive knockout (KO) mice were generated via the deletion
of mouse Cdkl5 exon 6, mimicking a splice site mutation in a patient that resulted in the
skipping of corresponding human CDKL5 exon 7 (Wang et al., 2012). No full-length
functional CDKL5 protein was detectable in the brains of these Cdkl5 KO mice. Male KO
mice exhibited normal growth, brain and body weight, and lack of gross brain pathology
(Wang et al., 2012). However, a battery of behavioral assays revealed adult Cdkl5 KO
5

mice to have deficits in multiple domains, including alterations in anxiety-related
phenotypes, locomotion activity, impaired motor coordination, social interaction deficits,
increased repetitive behaviors, and impaired learning and memory (Wang et al., 2012),
mirroring the numerous comorbidities of human CDD. Furthermore, Cdkl5 KO mice
showed abnormal auditory event-related potentials (ERPs) reflective of long-range circuit
communication deficits (Wang et al., 2012). Three subsequent studies, two of which
generated independent Cdkl5 KO alleles, replicated the majority of these behavioral
findings (Amendola et al., 2014; Jhang et al., 2017; Okuda et al., 2018), although some
discrepancies exist, likely due to differences in background strains, protocols, and
specific parameters in assessing behavioral phenotypes.

Network, Circuit, and Cellular Phenotypes of CDKL5-Deficient Mice
To date, a total of three distinct Cdkl5 KO mouse lines have been generated
(Amendola et al., 2014; Okuda et al., 2017; Wang et al., 2012). The lack of spontaneous
seizures and obvious electrographic abnormalities in adult Cdkl5 KO mice, despite EEG
monitoring at multiple ages, has been a surprising but consistent finding. Seizure
threshold in Cdkl5 KO mice has also been assessed through the use of
chemoconvulsants, including kainate and N-methyl-D-aspartic acid (NMDA) (Amendola
et al., 2014; Okuda et al., 2017). Both juvenile (4-week) and adult (13 week) Cdkl5 KO
mice were found to be differentially susceptible to NMDA, but not kainate (Okuda et al.,
2017), suggesting a potential underlying change in network excitability.
At the cellular level, neuronal morphology has been consistently found to be
altered in vitro in cultured neurons upon CDKL5 knockdown and in vivo in Cdkl5 KO
6

mice. Specifically, dendritic arborization is reduced in multiple brain regions in adult
Cdkl5 KO mice (Amendola et al., 2014; Fuchs et al., 2014; Tang et al., 2017). Spine
density has also been found to be altered, but the specific changes have been contextdependent, with some studies discovering an excess of “immature” spines and others
discovering reduced spine number and stability (Ricciardi et al., 2012; Sala et al., 2016).
Related to these morphologic changes, excitatory synaptic activity (Ricciardi et al., 2012;
Sala et al., 2016; Tang et al., 2017), microcircuit activity (Tang et al., 2017), and synaptic
plasticity in the form of long-term potentiation (Okuda et al., 2017; Sala et al., 2016) have
all been found to be altered, although the specific changes again appear to be highly
context-dependent.

Genetic Dissection of the Cellular Origins of CDD-Related Phenotypes
An imbalance in excitation and inhibition (E/I) is thought to be a fundamental
network mechanism that underlies behavioral abnormalities in neurodevelopmental
disorders (Rubenstein and Merzenich, 2003). The balancing forces of excitation and
inhibition are apparent in the cellular architecture of many brain regions, particularly the
cortex and hippocampus, where excitatory glutamatergic pyramidal neurons are
modulated by inhibitory GABAergic interneurons (Harris and Mrsic-Flogel, 2013;
Tremblay et al., 2016). A disruption of either glutamatergic or GABAergic signaling,
resulting in an overall E/I imbalance, is a frequent finding in animal models, with many
studies demonstrating changes originating at the synaptic level (Lee et al., 2017; Nelson
and Valakh, 2015). For specific disorders, the underlying mechanism of E/I imbalance
has been attributed to the dysfunction of subsets of genetically defined neurons, in that
conditional knockout mice are capable of recapitulating many of the phenotypes of the
7

respective constitutive knockout (Chao et al., 2010; Judson et al., 2016). These findings
have not only provided mechanistic insight into the circuit and network changes that
generate abnormal behavior, but also motivated the investigation of specific cell- and
circuit-based therapies that seek to ameliorate behavioral deficits (Sahin and Sur, 2015;
Tyson and Anderson, 2014).
In mice, CDKL5 expression is highest in the forebrain, but found in both
excitatory glutamatergic and inhibitory GABAergic neurons (Johnson et al., 2017; Wang
et al., 2012). The complex constellation of phenotypes found in Cdkl5 KO mice raises an
intriguing question: do these behavioral phenotypes originate from common or distinct
cellular and circuit mechanisms? More specifically, how does the loss of CDKL5 lead to
the dysfunction of glutamatergic and GABAergic neurons and consequently, the
neuronal circuits and networks that generate behavior? Similar to previous studies
involving Mecp2 and Ube3a (Chao et al., 2010; Judson et al., 2016), we took advantage
of genetic Cre-expressing mouse lines (Goebbels et al., 2006; Monory et al., 2006) that
defined these broad classes of neurons and began our investigation through the
generation of Cdkl5 conditional knockout (cKO) mice. By conducting assays at multiple
levels, we sought to 1) dissect the cellular origins of the behavioral phenotypes of CDD
in mice, and 2) gain mechanistic insight into the roles of CDKL5 in synaptic and circuit
function.
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CHAPTER 2 – LOSS OF CDKL5 IN GLUTAMATERGIC NEURONS DISRUPTS
HIPPOCAMPAL MICROCIRCUITRY AND LEADS TO MEMORY IMPAIRMENT IN
MICE

Adapted from: Tang S, Wang ITJ, Yue C, Takano H, Terzic B, Pance K, Lee JY, Cui Y,
Coulter DA, Zhou Z. Loss of CDKL5 in glutamatergic neurons disrupts hippocampal
microcircuitry and leads to memory impairment in mice. Journal of Neuroscience. 2017
Jul;3:0539-17.

Abstract
CDKL5 deficiency disorder (CDD) is a neurodevelopmental disorder
characterized by epileptic seizures, severe intellectual disability, and autistic features.
Mice lacking cyclin-dependent kinase-like 5 (CDKL5) display multiple behavioral
abnormalities reminiscent of the disorder, but the cellular origins of these phenotypes
remain unclear. Here, we find that ablating CDKL5 expression specifically from forebrain
glutamatergic neurons impairs hippocampal-dependent memory in male conditional
knockout mice. Hippocampal pyramidal neurons lacking CDKL5 show decreased
dendritic complexity but a trend toward increased spine density. This morphological
change is accompanied by an increase in the frequency of spontaneous miniature
EPSCs and interestingly, miniature IPSCs. Using voltage-sensitive dye imaging to
interrogate the evoked response of the CA1 microcircuit, we find that CA1 pyramidal
neurons lacking CDKL5 show hyperexcitability in their dendritic domain that is
constrained by elevated inhibition in a spatially and temporally distinct manner. These
results suggest a novel role for CDKL5 in the regulation of synaptic function and uncover
an intriguing microcircuit mechanism underlying impaired learning and memory.
9

Introduction
CDD is characterized by early-onset epilepsy, severe intellectual disability,
autistic features, and various comorbidities (Bahi-Buisson and Bienvenu, 2012; Fehr et
al., 2016a; Kalscheuer et al., 2003; Weaving et al., 2004). It is caused by mutations in
the X-linked gene, cyclin-dependent kinase-like 5 (CDKL5), a member of a highly
conserved family of serine-threonine kinases (Kilstrup-Nielsen et al., 2012). Mice that
constitutively lack CDKL5 recapitulate several key features of the disorder, including
impaired hippocampal-dependent memory, deficits in motor coordination, and autisticlike phenotypes such as reduced sociability and increased repetitive behavior
(Amendola et al., 2014; Fuchs et al., 2014; 2015; Wang et al., 2012). However, the
cellular origins and circuit mechanisms contributing to these phenotypes have yet to be
identified, thus limiting the insight into the pathogenic mechanisms that underlie CDD.
Cdkl5 mRNA and protein expression is highly enriched in neurons of the
forebrain (Wang et al., 2012), where glutamatergic and GABAergic cell types
predominate (Hébert and Fishell, 2008; Poulin et al., 2016). In excitatory neurons,
CDKL5 has been found to localize to the postsynaptic density, where it interacts with
postsynaptic density protein 95 (PSD-95), netrin-G1 ligand (NGL-1), and Rac1 (Chen et
al., 2010; Ricciardi et al., 2012; Zhu et al., 2013). CDKL5 knockdown or constitutive
knockout result in changes in the dendritic branching, spine density, and synaptic
function of glutamatergic neurons (Chen et al., 2010; Ricciardi et al., 2012; Sala et al.,
2016; Zhu et al., 2013). However, the directionality of these changes appears to be
highly context-dependent. For example, shRNA-mediated knockdown of CDKL5 in
cultured mouse hippocampal neurons leads to an increase in immature spine numbers
(Ricciardi et al., 2012), whereas downregulation of CDKL5 by the in utero electroporation
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of an shRNA construct in the rat reduces overall spine density (Zhu et al., 2013). In adult
Cdkl5 constitutive knockout mice, both spine stability and spine density are reduced in
the somatosensory cortex (Sala et al., 2016). Given that CDKL5 is also expressed in
GABAergic neurons (Rusconi et al., 2008), the extent to which these cellular and
morphological phenotypes are the result of cell-autonomous dysfunction in excitatory
neurons or a consequence of loss of CDKL5 in GABAergic neurons remain unknown.
Furthermore, how these cellular phenotypes contribute to functional deficits at the
synapse, circuit, and even behavioral level remains to be determined.
Given that CDKL5 is highly expressed in excitatory neurons and is localized to
the postsynaptic density of excitatory synapses, we carried out conditional knockout
studies of CDKL5 in excitatory neurons and set out to 1) determine the contribution of
excitatory neuronal dysfunction to behavioral abnormalities in CDD, 2) investigate how
CDKL5 loss affects dendrite and spine morphology in vivo in mice, 3) examine the
resulting synaptic and circuit dysfunction in a behaviorally relevant microcircuit. We find
that loss of CDKL5 in forebrain excitatory neurons impairs hippocampal-dependent
memory and alters neuronal morphology. In addition, hippocampal pyramidal neurons
lacking CDKL5 show enhanced spontaneous synaptic activity, evidenced by the
elevation of mEPSC and mIPSC frequency. Interestingly, the alteration of synaptic
excitation and inhibition leads to a complex, layer-specific disruption of CA1 microcircuit
dynamics. Our findings suggest a glutamatergic neuron-specific mechanism for learning
and memory impairment in CDD and reveal a novel role for CDKL5 in regulating
synaptic and circuit function in vivo.
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Results
Nex-cKO mice exhibit impaired hippocampal-dependent learning and memory
Cdkl5 constitutive knockout mice exhibit a broad range of behavioral phenotypes,
including impaired learning and memory, decreased social behavior, increased repetitive
behavior, decreased anxiety-related behavior, and impaired motor coordination
(Amendola et al., 2014; Fuchs et al., 2014; 2015; Wang et al., 2012). CDKL5 protein
expression is highest in the forebrain (Wang et al., 2012), where glutamatergic and
GABAergic neurons predominate. To isolate the cellular origins of CDD-related
phenotypes, we generated a mouse line selectively lacking CDKL5 in forebrain
excitatory neurons (Nex-cKO), using the Nex-Cre mouse line (Goebbels et al., 2006)
(Fig. 1A). We then confirmed the cell type-specific loss of CDKL5 in excitatory neuronrich regions of the forebrain using western blot analysis of microdissected tissues (Fig.
1B). In whole hippocampal lysates of Nex-cKO mice, CDKL5 protein levels were
reduced by ~85% (WT, 0.445, Nex-cKO, 0.068; Mann-Whitney test, U=0, p=0.029) (Fig.
1C). We first carried out a battery of behavioral tests to assess basic sensory and motor
functions, including home-cage locomotion, anxiety-related behavior, rotarod, olfaction,
repetitive behavior, and nesting, and found that these behaviors were unaltered in NexcKO mice compared to wild type littermates (Fig. 2A-F). Interestingly, we noted the
emergence of a robust hind limb clasping phenotype in Nex-cKO starting at around
postnatal day (P) 80 that became fully penetrant by approximately P120 (Fig. 2G).
We next assessed sociability and learning and memory, two aspects of behavior
impaired in constitutive Cdkl5 knockout mice that mirror the symptomatology of human
CDD (Wang et al., 2012). Compared to wild type littermates, adult Nex-cKO mice
demonstrated similar social behavior in the three-chamber social approach test, showing
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a strong preference for investigating a novel mouse over a novel object (Fig. 3A,B), as
well as similar levels of direct social interaction with a novel mouse (WT, 64.1±7.3; NexcKO, 53.4±3.9, Mann-Whitney test, p=0.55) (Fig. 3C). In contrast, on the Y-maze test,
Nex-cKO mice exhibited significantly decreased spontaneous alternation (WT,
65.9±2.2%; Nex-cKO, 53.9±2.3%; unpaired t-test, t41=3.737, p=0.0006) (Fig. 4A),
suggestive of an impairment in spatial working memory. On the Barnes maze assay,
Nex-cKO mice made more errors on both forward (WT, 44.3±5.0 errors; Nex-cKO,
71.8±5.8 errors; unpaired t-test, t26=2.991, p=0.006) and reversal (WT, 52.1±5.7 errors;
Nex-cKO, 71.8±5.8 errors; Mann-Whitney test, U=19, p=0.0005) probe trials, and
showed increased number of perseverations (WT, 2.4±0.4 errors; Nex-cKO, 5.1±0.4
errors; unpaired t-test, t26=3.896, p=0.0006) to the original target during the reversal
probe trial, suggesting a deficit in hippocampal-dependent memory (Fig. 4C-E).
Interestingly, Nex-cKO mice also showed modestly increased locomotor activity in
specific contexts outside of the home cage, as shown by higher activity during the social
choice phase of the social approach assay (WT, 23.4±1.0 m; Nex-cKO, 27.3±0.8 m;
Mann-Whitney test, U=311, p=0.0015) and increased total number of entries on the Ymaze assay (WT, 29.3±1.3 entries; Nex-cKO, 40.2±2.8 entries; unpaired t-test,
t41=3.294, p=0.002) (Fig 3D, 4B). Taken together, of the numerous phenotypes exhibited
by Cdkl5 constitutive knockout mice, Nex-cKO mice appear to recapitulate a relatively
isolated impairment in hippocampal-dependent learning and memory upon the loss of
CDKL5 from forebrain excitatory neurons.
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Altered morphology of CA1 pyramidal neurons of Nex-cKO mice
CDKL5 has been found to interact with proteins that modulate the actin
cytoskeleton (Chen et al., 2010) as well as the postsynaptic density (Ricciardi et al.,
2012). However, the impact of CDKL5 loss on pyramidal neuron morphology has been
highly context-dependent, varying across in vitro knockdown studies and in vivo studies
in Cdkl5 constitutive knockout mice (Chen et al., 2010; Ricciardi et al., 2012; Sala et al.,
2016; Zhu et al., 2013). The Nex-cKO mouse line presented us with a unique opportunity
to examine the excitatory neuron-autonomous consequences of CDKL5 loss on cellular
morphology. We chose to focus our morphologic studies on CA1 pyramidal neurons, due
to 1) previous findings suggesting that CDKL5 expression is highly enriched in the CA1
region (Cembrowski et al., 2016) and 2) the relatively specific impairment in
hippocampal-dependent learning and memory phenotype in Nex-cKO mice. By crossing
Nex-cKO mice with a Thy1-GFPm allele (Feng et al., 2000), we were able to analyze
dendritic complexity and dendritic spine density in vivo. Compared to wild type
littermates, adult Nex-cKO mice showed a significant decrease in the complexity of the
basal and proximal apical dendrites of CA1 neurons, as shown by Sholl analysis (Linear
mixed effect model analysis, interaction of genotype and distance from soma; basal
dendrites: F19,875=3.27, p=3.12x10-6; apical dendrites: F23,1051=2.26, p=0.001) (Fig. 5A-E),
confirming the results of a previous RNAi-mediated CDKL5 knockdown study (Chen et
al., 2010) and constitutive knockout study (Amendola et al., 2014). In Nex-cKO mice,
total basal dendrite length also showed a trend toward a reduction (Linear mixed effect
model analysis, fixed effect of genotype (Nex-cKO – WT), -458.9 μm, F1,4.42=4.86,
p=0.086) (Fig. 5D). Next, we compared spine density in CA1 pyramidal neurons of wild
type and Nex-cKO mice. In Nex-cKO mice, we found, surprisingly, trends toward an
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increase in spine density, particularly in the apical dendrites of CA1 pyramidal neurons
(Linear mixed effect model analysis, fixed effect of genotype (Nex-cKO – WT), 2.204
spines/10 μm, F1,3.5=8.22, p=0.054). (Fig. 6B, E). Reconstruction and analysis of spine
morphology in three-dimensional confocal image stacks also revealed a trend toward an
increase in spine volume in Nex-cKO mice (basal dendritic spines: linear mixed effect
model analysis, fixed effect of genotype (Nex-cKO – WT), 0.0234 μm 3, F1,3.63=5.88,
p=0.079) (Figure 6C, F). Given that spine volume is positively correlated with spine
maturity and the strength of the excitatory synapse it contains (Arellano et al., 2007;
Harris and Stevens, 1989; Nimchinsky et al., 2002), our findings suggest that CA1
pyramidal neurons in Nex-cKO mice tend to have slightly increased density of
morphologically mature dendritic spines.

Enhanced excitatory synaptic activity in CA1 pyramidal neurons of Nex-cKO mice
Because decreased dendritic branching and increased spine volume and density
are not typically observed in concert, we next asked how this morphology affected
function, particularly related to the intrinsic and synaptic properties of CA1 pyramidal
neurons. Using the whole-cell patch-clamp technique in ex vivo hippocampal slices, we
first investigated the intrinsic membrane properties and input-output properties of CA1
neurons in wild type and Nex-cKO mice. We found no significant differences in the
action potential threshold (Linear mixed effect model analysis, F 1,5.87=0.4, p=0.551) (Fig.
7A), input resistance (Linear mixed effect model analysis, F 1,5.97=0.73, p=0.427) (Figure
7B), and an input-output curve correlating the amount of injected current to the number
of action potentials (Linear mixed effect model analysis, F 6,204.02=0.75, p=0.611) (Figure
7C), suggesting that CA1 neurons lacking CDKL5 are comparable to wild type neurons
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in their intrinsic membrane properties and their ability to generate action potentials. Next,
we investigated excitatory synaptic transmission by recording miniature excitatory
synaptic currents (mEPSCs). In Nex-cKO mice, we found a significant reduction in
mEPSC inter-event intervals (Linear mixed effect model analysis, interaction of genotype
and cumulative frequency bin, F19,696=5.28, p=4.63x10-12), which resulted in a trend
toward increased overall mEPSC frequency (Linear mixed effect model analysis, fixed
effect of genotype, (Nex-cKO - WT), 0.58 Hz, F1,3.08=9.57, p=0.052) (Fig. 8B,C), whereas
mEPSC amplitude was unaltered (Linear mixed effect model analysis, F 1,3.93=0.28,
p=0.623) (Figure 8D-E).
Given the evidence supporting enhanced spontaneous excitatory synaptic
activity in Nex-cKO mice, we next asked whether this change represented a specific
enhancement of AMPA- or NMDA-dependent currents. To estimate the relative
contributions of AMPA- and NMDA-dependent currents in the same neuron, we
performed recordings of evoked EPSCs at holding potentials of -70 mV and +40 mV
(Etherton et al., 2009; 2011a). Nex-cKO mice showed similar amplitudes of the AMPA(Fig. 9A,C) and NMDA-dependent EPSC components of evoked EPSCs (Linear mixed
effect model analysis, AMPA-EPSC: F1,5.16=0.27, p=0.625; NMDA-EPSC: F1,4.65=0.54,
p=0.498) (Fig. 9B,D). Importantly, the NMDA/AMPA ratio was unaltered in Nex-cKO
mice (Linear mixed effect model analysis, F1,3.44=0.06, p=0.821). (Fig. 9E). These results
suggest that the enhancement of excitatory synaptic activity in Nex-cKO mice is unlikely
to be attributed to a specific change in ionotropic glutamate receptor subtype.
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Enhanced inhibitory synaptic activity in CA1 pyramidal neurons of Nex-cKO mice
Imbalances in excitation-inhibition (E/I) are commonly found in mouse models of
neurodevelopmental disorders and thought to underlie a range of pathologic
phenotypes, including impaired learning and memory (Bateup et al., 2013; Kepecs and
Fishell, 2014; Nelson and Valakh, 2015; Rubenstein and Merzenich, 2003; Sahin and
Sur, 2015; Shcheglovitov et al., 2013; Yizhar et al., 2011). Given our findings of
enhanced excitatory synaptic activity in Nex-cKO mice, we next investigated whether the
excitatory neuron-specific loss of CDKL5 also affects inhibitory synaptic transmission. To
assess inhibition, we carried out whole-cell patch clamp recordings of miniature
inhibitory postsynaptic currents (mIPSCs) from CA1 pyramidal neurons in wild type and
Nex-cKO mice. To avoid the potential confound of depolarization-induced suppression of
inhibition (Wilson and Nicoll, 2001) and other depolarization-induced changes, we used
a high-chloride internal solution that allowed the recording of mIPSCs at a voltage near
the resting membrane potential of CA1 pyramidal neurons. We found that CA1 pyramidal
neurons in Nex-cKO mice showed a significant reduction in mIPSC inter-event intervals
(Linear mixed effect model analysis, interaction of genotype and cumulative frequency
bin, F19,656=2.32, p=0.001), which resulted in a trend toward increased mIPSC frequency
(Linear mixed effect model analysis, fixed effect of genotype (Nex-cKO – WT), 0.792 Hz,
F1,3.5=7.83, p=0.057) (Fig. 10B,C), whereas mIPSC amplitude was unaltered (Linear
mixed effect model analysis, F1,3.5=0.01, p=0.92) (Fig. 10D,E), suggesting an
enhancement in spontaneous inhibitory synaptic activity onto pyramidal neurons.
Intriguingly, we also found a significant increase in mIPSC decay time (Linear mixed
effect model analysis, fixed effect of genotype (Nex-cKO – WT), 1.356 ms, F1,3.74=17.2,
p=0.016) (Fig. 10G). Together, the enhancement of mIPSC frequency and slowed decay
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kinetics in Nex-cKO mice contributed to a significantly enhanced inhibitory charge
transfer rate (Linear mixed effect model analysis, fixed effect of genotype (Nex-cKO –
WT), 213 pA*ms/s, F1,3.5=12.86, p=0.029) (Fig. 10H). These results suggest that as a
result of CDKL5 loss, CA1 pyramidal neurons in Nex-cKO mice show an enhancement
of both spontaneous excitatory and inhibitory synaptic activity.

Disrupted spatiotemporal dynamics of the CA1 microcircuit in Nex-cKO mice
Our whole-cell patch-clamp studies revealed an elevation of both excitatory and
inhibitory synaptic activity in Nex-cKO mice. An imbalance of excitation and inhibition,
therefore, is not readily apparent from these findings alone. However, our whole-cell
recordings assessed synaptic activity only at the soma and did not directly assess the
spatiotemporal integration of excitation and inhibition occurring along the dendrites of
pyramidal neurons. Given the distinct spatial distribution of excitatory and inhibitory
synapses in the dendritic and somatic domains of CA1 pyramidal neurons (Bloss et al.,
2016), increases in excitation and inhibition are not likely to “cancel out.” Therefore, we
next asked whether circuit function in Nex-cKO mice might be affected in a more
complex manner. To investigate the contribution of synaptic changes to a behaviorallyrelevant circuit function, we investigated how CA1 pyramidal neurons respond to
stimulation at the Schaffer collaterals, a source of monosynaptic excitatory input that is
critical for learning and memory in vivo. We used voltage-sensitive dye imaging (VSDI),
a technique that allows the quantitative analysis of evoked excitatory and inhibitory
responses across time and space (Carlson and Coulter, 2008; Coulter et al., 2011). In
order to compare Schaffer-evoked responses in CA1 regions of wild type and Nex-cKO
mice, we normalized stimulus intensities based on the excitability of individual slices. No
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significant differences were found for the half-maximal stimulus intensities (Linear mixed
effect model analysis, F1,6.27=1.1, p=0.332) and the elicited presynaptic fiber volley
amplitudes (Linear mixed effect model analysis, F 1,8.06=0.27, p=0.619) in WT and NexcKO mice, suggesting that comparable stimuli were used in our VSDI experiments (Fig.
12F, G).
To fully assess both the magnitude and spatial spread of VSDI responses, we
generated regions of interest (ROIs) in the stratum radiatum (proximal apical dendritic
layer) and stratum pyramidale/oriens (cell body and basal dendritic layer), both proximal
and distal to the site of stimulation (Fig. 11A). In wild type mice, Schaffer collateral
stimulation typically evokes a fast, temporally-restricted depolarization in stratum
radiatum that is followed by a hyperpolarizing response in the stratum pyramidale/oriens
(Fig. 11B, C, D, F), likely reflective of feedforward/feedback inhibition that is strongest in
the perisomatic region (Pouille and Scanziani, 2001). In contrast, Schaffer collateral
stimulation in Nex-cKO mice led to a significantly enhanced depolarization in stratum
radiatum in a region proximal to the stimulus (Linear mixed effect model analysis,
interaction of genotype and time, F5,201.55=3.97, p=0.002; generalized linear hypothesis
tests with Holm’s method to adjust for multiple comparisons, 8 ms: z=3.79, p=9.06x10-4;
10 ms: z=3.01, p=0.013) (Fig. 11F and Fig. 12C), demonstrating dendritic
hyperexcitability consistent with the observed increase in spontaneous excitatory
synaptic activity. Paired-pulse ratios from extracellular field recordings in the stratum
radiatum were similar between wild type and Nex-cKO mice (Linear mixed effect model
analysis, F1,7.91=0.002, p=0.966) (Fig. 12I), suggesting that the observed dendritic
hyperexcitability is unlikely to be of presynaptic origin, which is also consistent with
previous findings localizing CDKL5 to the postsynaptic density (Ricciardi et al., 2012).
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Interestingly, in the stratum pyramidale/oriens of Nex-cKO mice proximal to the stimulus,
we observed an enhancement of both depolarization and hyperpolarization (Linear
mixed effect model analysis, interaction of genotype and time, F 5,201.30=7.61, p=1.42x106

; generalized linear hypothesis tests with Holm’s method to adjust for multiple

comparisons, 8 ms: z=3.28, p=0.0062; 10 ms: z=2.66, p=0.039; 40 ms: z=-2.38, p=0.07)
(Fig. 11D and Fig. 12A), suggesting an increase in perisomatic inhibition that is
consistent with our finding of increased spontaneous inhibitory synaptic activity.
However, in the stratum pyramidale/oriens distal to the site of the stimulus, Nex-cKO
mice showed only enhanced hyperpolarization (Linear mixed effect model analysis, of
genotype and time, F5,201.20=2.25, p=0.051; generalized linear hypothesis tests with
Holm’s method to adjust for multiple comparisons, 20 ms, z=-3.1, p=0.012) (Fig. 11E
and Fig. 12B), suggesting that the spread of excitation is highly constrained in space by
enhanced inhibition. Taken together, these results 1) confirm the dual enhancement of
both excitatory and inhibitory synaptic activity identified in whole-cell recordings and 2)
show that, due to the differential spatial distribution of excitatory and inhibitory synapses,
the dual enhancement does not “cancel out” but rather, alters the activation of the CA1
circuit in a spatially and temporally distinct manner (Fig. 13).

Discussion
In this study, we uncover the cellular origins of learning and memory impairment
in a mouse model of CDD through the generation of a forebrain excitatory neuronspecific Cdkl5 knockout line (Nex-cKO). Nex-cKO mice demonstrate impaired
hippocampal-dependent memory, along with context-dependent hyperactivity and hind
limb clasping. At the cellular level, we observe that altered neuronal morphology in Nex20

cKO mice is accompanied by increased spontaneous excitatory and inhibitory synaptic
activity, leading to altered spatiotemporal dynamics in the CA1 microcircuit that is
relevant to learning and memory. Together, these findings reveal the glutamatergic
origins of learning and memory impairment in CDD and support a novel role for CDKL5
in regulating synaptic and circuit function in glutamatergic neurons.
We chose to focus on male hemizygous conditional knockout mice to examine
the role of CDKL5 in excitatory neurons, avoiding the potential confound introduced by
random X-inactivation in heterozygous females, which leads to mosaic CDKL5 protein
expression. However, because most patients with CDD are female, future studies should
aim to determine, in female heterozygous knockout and conditional knockout mice, the
nature and extent of cellular and circuit abnormalities, and how these changes are
affected by variable patterns of X-inactivation. In this regard, the development of tools to
discriminate Cdkl5 expression at cellular resolution in mosaic females will greatly
facilitate the investigation of cellular and circuit endophenotypes and behavioral deficits.

Disruption of hippocampal-dependent memory in Nex-cKO mice
The finding of a relatively isolated deficit in hippocampal-dependent memory in
Nex-cKO mice suggests that these symptoms in CDD likely have origins in the
glutamatergic neuron, while other features likely arise from different cell types and
associated circuits. These results point toward the value of a cell type-specific approach
to isolate the cellular signaling changes underlying CDD-related phenotypes. For
example, biochemical studies in Cdkl5 constitutive knockout mice to date have focused
on the cortex and hippocampus, regions where glutamatergic neuron types predominate
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(Hébert and Fishell, 2008; Poulin et al., 2016). Therefore, the changes in AKT-mTOR
pathway activity (Amendola et al., 2014; Sala et al., 2016; Wang et al., 2012) and the
phosphorylation of molecules such as GSK3β (Fuchs et al., 2014; 2015) and HDAC4
(Trazzi et al., 2016) reported likely represent the consequences of CDKL5 loss from
glutamatergic neurons. Interestingly, pharmacologic treatment targeting these signaling
changes appear to ameliorate learning and memory deficits in Cdkl5 constitutive
knockout mice (Fuchs et al., 2015; Trazzi et al., 2016), although other phenotypes have
not yet been examined. Our findings confirm the importance of glutamatergic signaling in
hippocampal-dependent learning and memory in CDD, but suggest that other features of
CDD may arise from distinct cellular origins and may therefore involve distinct signaling
pathways. Therefore, additional studies are necessary to determine the function of
CDKL5 in other cell types, which may underlie symptoms such as reduced sociability,
altered anxiety-related behavior, and impaired motor coordination. For example, in the
forebrain, where CDKL5 expression is enriched, GABAergic neurons constitute a second
cell type that merits further investigation.
Similar to reports from Cdkl5 constitutive knockout mice (Amendola et al., 2014;
Wang et al., 2012), we did not find any evidence of spontaneous behavioral seizures in
Nex-cKO mice. The contribution of genetic background to seizure susceptibility and
differences in brain connectivity between humans and mice (Oh et al., 2014) are likely
the cause. However, our results reveal a potential circuit-level mechanism for
hyperexcitability, supporting a conserved role for CDKL5 in regulating the excitability of
neuronal networks.
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Altered CA1 pyramidal neuron morphology in Nex-cKO mice
Our morphological studies reveal two sets of changes that stand in contrast to
one another – reduced dendritic complexity and trends toward increased spine density
and volume. One possibility is that the reduction in dendritic complexity is a secondary,
homeostatic response to altered spine density and morphology and enhanced excitatory
synaptic activity. Activity-dependent dendritic retraction is known to occur both in vivo
and in vitro and has been documented in a model of Timothy syndrome involving a
mutation in the voltage-gated calcium channel CaV1.2 (Krey et al., 2013; Wong and
Ghosh, 2002). Interestingly, elevated GSK-3β activity, which is associated with activitydependent shrinkage of dendrites (Rui et al., 2013), has been found in mouse models of
CDD (Fuchs et al., 2014). The converse possibility, altered spine density and
morphology being secondary to reduced dendritic complexity, seems less likely in the
setting of an overall increase in excitatory synaptic activity in Nex-cKO mice. Because
these contrasting findings typically do not accompany each other in models of
neurodevelopmental disorders (Penzes et al., 2011), a third possibility is simply that
CDKL5 regulates dendrite and synapse development through distinct mechanisms. This
hypothesis may be consistent with recent findings in which neuronal activity in immature
neurons leads to the induction of CDKL5 protein levels, while neuronal activity in mature
neurons leads to the degradation of CDKL5 (La Montanara et al., 2015). CDKL5,
therefore, may have distinct functions during stages of development that uniquely affects
the processes of dendrite growth, spine generation, and activity-dependent pruning. One
such example of a family of kinases that serve two contrasting cellular functions is the
doublecortin-like kinases (DLCKs), which promote dendrite growth but suppress
synapse maturation (Shin et al., 2013).
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Altered synaptic inhibition in Nex-cKO mice
Given that we selectively ablated CDKL5 expression from excitatory neurons, we
were surprised to find altered inhibition in Nex-cKO mice. CDKL5 is not believed to
interact with inhibitory synaptic proteins (Ricciardi et al., 2012), and it therefore may be
tempting to conclude that the observed increase in inhibition in Nex-cKO is a
compensatory response by GABAergic cells to mitigate E/I balance. However, such
compensatory changes in GABAergic synaptic activity do not typically accompany
increased excitatory synaptic activity and circuit hyperexcitability in other animal models
(Bateup et al., 2013; Chao et al., 2010; Flavell et al., 2006; Luikart et al., 2011; Tsai et
al., 2012). A recent study in constitutive Cdkl5 knockout mice discovered an upregulation
of parvalbumin- and VGAT-positive puncta at the cell bodies of pyramidal neurons in the
visual cortex (Pizzo et al., 2016). This finding is consistent with our results, which
suggest an enhancement of perisomatic inhibition in the hippocampal CA1 region of
Nex-cKO mice. Interestingly, our whole-cell recordings also revealed a significant
enhancement of mIPSC decay time, potentially suggesting an alteration in the
composition of GABAA receptor subunits (Goldstein et al., 2002). Therefore, it is possible
that CDKL5 also regulates inhibitory synaptic function through a distinct mechanism that
has yet to be discovered. For example, CDKL5 kinase activity may regulate the
localization and function of postsynaptic scaffolding proteins such as gephyrin or
subunits of the GABA receptor in excitatory neurons through post-translational
modification.
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Disrupted microcircuit dynamics in Nex-cKO mice
Our voltage-sensitive dye imaging results suggest that the enhancement of
excitatory and inhibitory synaptic activity do not neatly “cancel out”. Voltage-sensitive
dye imaging allowed the analysis of the spread of excitation and inhibition, capturing, in
Nex-cKO mice, hyperexcitation that was spatiotemporally constrained by elevated
inhibition (Fig. 11 and Fig. 12). Given the interactions of the Schaffer collateral pathway
with direct cortical input in vivo (Ang et al., 2005; Backus et al., 2016; Colgin, 2016), it is
not surprising that such a circuit disturbance could underlie behavioral dysfunction. A
prolonged Schaffer-evoked IPSP in Nex-cKO mice could impair oscillations across
multiple frequency bands in vivo and have profound effects on neuronal firing patterns
and synaptic plasticity, both of which could contribute to deficits in learning and memory.
Our findings emphasize the value of circuit profiling, particularly in models where
multiple synaptic abnormalities are present. Given increasing evidence supporting the
circuit specificity of neurophysiological findings in animal models (DeNardo et al., 2012;
Etherton et al., 2011b; O’Hare et al., 2016; Qiu et al., 2011; Shepherd and Katz, 2011),
targeted analysis of behaviorally relevant cell types and associated microcircuits are
most likely to yield insight into the mechanisms responsible for pathological phenotypes.
For example, a recent study found that the loss and gain of MeCP2 in mice led to
convergent phenotypes of CA1 pyramidal neuron hypersynchrony (Lu et al., 2016). In
addition, chronic forniceal deep-brain stimulation (DBS) can rescue both impaired
learning and memory and underlying circuit dysfunction across these multiple models of
Rett syndrome (Hao et al., 2015; Lu et al., 2016), illustrating the potential of neural circuit
studies to reveal avenues of therapy in disorders with diverse molecular etiologies. Our
findings that CDKL5 plays an essential role in excitatory neurons to regulate
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hippocampal-dependent memory and circuit function suggest that in addition to
therapies that seek to correct the underlying signaling changes, the modulation of circuit
activity may also serve as a therapeutic target to ameliorate CDD-associated learning
and memory deficits.

Materials and Methods

Generation of Cdkl5 conditional knockout mice. An identical targeting construct and
strategy was used from the generation of Cdkl5 constitutive knockout mice (Wang et al.,
2012). The targeting construct was confirmed by sequencing, linearized, and
subsequently electroporated into mouse sv129 ES cells. Correctly targeted ES cell
clones were independently injected into C57BL/6 blastocysts and subsequently
implanted into pseudopregnant females. Chimeric offspring were backcrossed to
C57BL/6, and the F1 hybrid bred to FLP deleter mice for removal of the neomycin
cassette. In tissues expressing Cre recombinase, the excision of exon 6 results in the
same genetic lesion as the previously generated Cdkl5 constitutive knockout line,
causing a reading frame shift and a TAA stop codon in the 5′ end of exon 7, resulting in
the truncation of CDKL5 at the N-terminal kinase domain. The Cdkl5 floxed mouse line is
available at Jackson Laboratory (Stock No. 030523).
Animal husbandry. Experiments were conducted in accordance with the ethical
guidelines of the National Institutes of Health and with the approval of the Institutional
Animal Care and Use Committee of the University of Pennsylvania. The Cdkl5flox allele
was generated on a congenic sv129:C57BL/6 background and backcrossed to C57BL/6
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for at least 10 generations. Nex-Cre mice (Goebbels et al., 2006) (RRID: MGI: 4429523),
generously shared by Professor Klaus-Armin Nave (Max Planck Institute of Experimental
Medicine, Göttingen, Germany) and Professor Eros Lazzerini Denchi (The Scripps
Research Institute, La Jolla, CA), were obtained on a sv129 background and also
backcrossed to C57BL/6 for at least 10 generations before breeding. Mice were
genotyped using a PCR-based strategy to detect the presence of the Cdkl5 conditional
knockout allele containing a loxP-flanked exon 6. The genotyping primers (5’CCACCCTCTCAGTAAGGCAGCAG-3’ and 5’-GTCCTTTTGCCACTCAATTCCATCC-3’
give rise to a 653-bp product from the wild-type allele and 765-bp product from the
conditional knockout allele with unexcised exon 6. For genotyping of Nex-Cre, primers
and genotyping strategy were identical to that used in Goebbels et al, 2006.
Mice were group-housed in cages of three to five in a 12-h light/dark cycle with
food and water provided ad libitum. Each breeding cage consisted of two homozygous
female mice (genotype: Cdkl5flox/Cdkl5flox) and one male mouse (genotype: Nex-Cre/+).
Male littermates (genotypes: Cdkl5flox/y;+/+ and Cdkl5flox/y;Nex-Cre) were weaned at 3
weeks of age and housed together, with all experiments performed on age-matched
adult mice between 9 and 12 weeks of age.
For spine imaging, homozygous female mice (genotype: Cdkl5flox/Cdkl5flox) were
bred to male mice carrying an allele expressing Thy1-GFP (line M) (RRID:
IMSR_JAX:007788). Male littermates (genotypes: Cdkl5flox/y;+/+;Thy1-GFPm/+ and
Cdkl5flox/y;Nex-Cre;Thy1-GFPm/+) were weaned at 3 weeks of age and housed
together, with all experiments performed on age-matched adult mice between 9 and 12
weeks of age.
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Western blot. Adult male mice (genotypes: Cdkl5flox/y;+/+ and Cdkl5flox/y;Nex-Cre) were
sacrificed by cervical dislocation. After decapitation, brains were removed and sectioned
into 1 mm coronal slices using a mouse brain matrix. Tissue was dissected from the
somatosensory cortex, striatum, hippocampus, and cerebellum and homogenized in
lysis buffer containing 1% NP-40, pH 8.0. Protein concentration was measured using the
Bradford assay and a total of 20 μg protein was loaded for each lane.
Primary antibodies used in this study are anti-N-terminal CDKL5 (generated in
Wang et al, 2012; diluted 1:500), anti-GAPDH (MA5-15738, Invitrogen; RRID:
AB_10977387 ;diluted 1:1000), and anti-β actin (AB8226, Abcam; RRID: AB_306371;
diluted 1:1000). Secondary antibodies (Licor) are goat anti-rabbit IRDye 800CW (RRID:
AB_10796098) and donkey anti-rabbit IRDye 680RD (RRID: AB_10954442) at dilutions
of 1:10,000. Standard protocols were used for the Odyssey Infrared Imaging System for
visualization and quantification.
Behavioral assays. All animal behavioral studies were carried out blinded to genotype.
Mice were allowed to habituate to the testing room for at least 1 hour before the test, and
testing was performed at the same time of day. All animal behaviors were performed on
adult male mice at 9-12 weeks of age, and the analysis of behavioral data was carried
out by a researcher blinded to genotype.
Elevated zero maze. The elevated zero maze (Stoelting, Illinois, USA) consists of a
circular-shaped platform elevated above the floor. Two opposite quadrants of the maze
are enclosed (wall height, 12 inches), whereas the other two are open (wall height, 0.5
inches). Mice were placed in one of the closed quadrants and their movement traced
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over the course of 5 min. Analysis, including the quantification of percent of time spent in
open arms and the number of entries, was performed manually using a stopwatch. An
entry was defined as a transition from a closed to open arm, or vice versa, that involves
all four paws.
Three-chambered social approach assay. The social approach assay was performed
as previously described (Fairless et al., 2013; Sankoorikal et al., 2006). The social
choice test was carried out in a three-chambered apparatus that consisted of a center
chamber and two end chambers. Before the start of the test and in a counter-balanced
sequence, one end chamber was designated the “social chamber,” into which a stimulus
mouse would be introduced, and the other end chamber was designed the “nonsocial
chamber.” Two identical clear, Plexiglas cylinders with multiple holes to allow for air
exchange were placed in each end chamber. In the habituation phase of the test, the
test mouse was placed in the center chamber and allowed to explore all three chambers
for 10 min. During this acclimation period, baseline measurements of how much time the
mouse spent in each of the three chambers and the distance traveled by the test mouse
were collected.
In the social choice phase of the test, a stimulus mouse (adult gonadectomized
A/J mice; The Jackson Laboratory) was placed in the cylinder in the social chamber
while a novel object was simultaneously placed into the other cylinder in the non-social
chamber. During the 5-min social choice period, chamber times and numbers of
transitions among chambers were again recorded.
In the direct social interaction test, the cylinders were removed simultaneously
following the social choice test, and the amount of time test and stimulus mice spent in
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direct contact (sniffing, allogrooming) was measured. If fighting persisted for more than
several seconds, the mice were removed from the apparatus and excluded from the
study.
Y-maze. Spontaneous alternation behavior was measured on a Y-maze apparatus (San
Diego Instruments, California, USA), composed of three arms (Arm A: 8’’x5’’x3’’; Arms B
and C: 6’’x5’’x3’’). For habituation, the test mouse was placed in each of the three arms,
facing the center, and allowed to make one choice to enter another arm. For testing, the
mouse was placed in Arm C, facing the center, and allowed to freely explore the maze
for 5 min. A spontaneous alternation was defined an entry into the arm less recently
explored. Percent spontaneous alternation was calculated as the number of
spontaneous alternations over the total number of entries. For example, the sequence
C,B,A,B,C,B,A,C (starting in arm C) resulted in a percent spontaneous alternation of 4/6
= 67%.
Barnes maze. Hippocampal-dependent memory was assessed on a Barnes Maze
apparatus (San Diego Instruments, California, USA), a circular platform with 36’’
diameter and 20 equally spaced escape holes along the perimeter, one of which leads to
a “target” escape box. Bright lighting was used as stimulus to complete the task. The
assay consisted of five phases: adaptation, forward acquisition training, forward probe
trials, reversal training, and reversal probe trials. For adaptation, each mouse was
placed in a dark start chamber in the middle of the maze for 10 s, then uncovered and
guided gently to the escape box. Forward acquisition training consisted of 2 trials per
day for 4 days, with each mouse starting in the dark start chamber in the middle of the
maze and subsequently allowed to explore the maze for 3 minutes. The trial ends when
the mouse enters the target escape hole or after 3 min have elapsed, after which the
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mouse is guided gently to the escape hole. After reaching the escape hole, the mouse is
allowed to remain there for 1 min. Forward probe trials were conducted on day 5, 24 hr
after the last training day. During the probe trial, the maze is in the same position as the
training days, and the target hole is closed. Each trial lasted 90 s, during which the
number of errors (pokes into non-target holes) made prior to reaching the target hole is
quantified. Days 6-10 consisted of reversal training, conducted using a similar protocol
as forward acquisition training, except that the target was a stable escape hole moved
180° from its location during forward acquisition training. Reversal probe trials were
conducted on day 11 and identically to forward probe trials. In addition to quantifying the
number of total errors, the number of perseverations, defined as pokes into the previous
target hole during forward acquisition training, was counted.
Locomotor assay. Locomotor activity was measured by beam breaks in a photobeam
frame (Med Associates, Vermont, USA). Mice were individually placed into a clean home
cage-like environment lined with bedding and resting within a photobeam frame. The
number of beam breaks as a measure of locomotor activity was quantified over 30 min in
5-min bins.
Accelerating Rotarod assay. Mice were placed on an accelerating Rotarod apparatus
(Med Associates) for 25 trials (5 trials a day on 5 consecutive days) with at least 15 min
of rest between the trials. Each trial lasted for a maximum of 5 min, during which the rod
accelerated linearly from 3.5 to 35 rpm. The amount of time for each mouse to fall from
the rod was recorded for each trial.
Olfaction. Mice were tested for whether they could detect and differentiate odors in a
habituation-dishabituation protocol modified from Yang and Crawley. Mice were
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presented with cotton-tipped wooden applicators dipped in water, vanilla, or swiped
across the bottom of an unfamiliar social cage. Each stimulus was presented for 2 min
with a 1-min inter-trial interval. Time spent sniffing was defined as when the animal was
oriented with its nose 2 cm or closer toward the cotton tip.
Repetitive behavior. Mice were individually placed into a clean home cage-like
environment lined with bedding. After allowing 5 min for habituation, 10 min of activity
was videotaped for each mouse. The duration of repetitive behavior, defined as
grooming or digging, was scored manually using a stopwatch.
Nesting. Nesting behavior was scored as previously described (Deacon, 2006). Four- to
five-week old mice were assessed for amount of cotton material used after 20 h and for
the height and shape of the nest.
Hind limb clasping. Mice were suspended by the base of their tail at least 6 inches
above a flat surface for up to 2 minutes. If a period of sustained clasping (at least 2 s) of
the hind limbs or all four limbs were observed, the mouse was scored as a positive for
the hind limb clasping phenotype.
Dendritic branching and dendritic spine analysis. All steps of sectioning, imaging,
and data analysis were performed by a researcher blinded to genotype. Adult male mice
9 weeks of age (genotypes: Cdkl5flox/y;+/+;Thy1-GFPm/+ and Cdkl5flox/y;Nex-Cre;Thy1GFPm/+) were transcardially perfused with 4% paraformaldehyde. Brains were extracted
and post-fixed additionally for 1 hr. For dendritic branching analysis, brains were
embedded in 2% agar and sectioned coronally at 200 μm on a Leica VT1000S
vibratome. For dendritic spine analysis, brains were cryoprotected by sinking in 30%
sucrose in PBS, frozen in OCT (Sakura Finetek, California, USA). Frozen brains were
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sectioned coronally at 50 μm on a Leica CM3050S cryostat. For both dendrite and spine
imaging, unstained sections were mounted with CFMR2 (Citifluor, London, UK).
GFP-positive pyramidal neurons located in the hippocampal CA1 region
(approximately between Bregma coordinates -1.34 to -1.94) with well-preserved
morphology were chosen for imaging. For dendritic branching, confocal image stacks
were taken on a laser scanning confocal microscope (Leica TCS SP8, 488 laser) with a
20X/0.75NA immersion objective at 1X zoom. Each neuron was oriented diagonally and
centered in a field of view with dimensions 553.57 μm x 553.57 μm, with a step size of
0.5 μm. For dendritic spines, secondary and tertiary dendritic branches of basal and
proximal apical dendrites, excluding the apical tuft, of CA1 pyramidal neurons were
imaged. Image stacks were taken with a 63x/1.40NA oil immersion objective at 4X
zoom. Each dendritic segment was centered in a field of view with dimensions 43.93 μm
x 10.95 μm, with a step size of 0.22 μm and total depth spanning a depth of less than 7
μm.
All image analysis was performed by a researcher blinded to genotype. For
dendritic branching analysis, the dendrites of each neuron was traced in a supervised
manner using Imaris FilamentTracer (Bitplane, Massachusetts, USA) (RRID:
SCR_007366). Each branch was individually traced using a combination of the Autopath
and Autodepth functions, with the center of the soma designated as the dendrite
beginning point. The basal and apical dendritic trees were separately traced. Sholl
analysis was automatically performed by Imaris, and the statistics were exported for
analysis.
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For spine analysis, 3-dimensional blind deconvolution was first performed on
confocal image stacks with an iterative constrained Tikhonov-Miller algorithm
(DeconvolutionLab, ImageJ) using a point-spread function generated from the imaging
parameters (PSF Generator, ImageJ). The deconvolved image stack was imported into
Imaris and analyzed. The dendritic backbone of each segment was first traced using the
Autopath function and a cone-type dendrite diameter was built using a contrast threshold
of 0.2 and dendrite maximum diameter of 1 μm. A sample spine was drawn from the
dendritic backbone using the Autopath function. Subsequently, seed points for spine
heads with a maximum distance of 3 μm from the dendritic backbone, with the manual
addition of seed points for any longer spines and curation of obvious false-positives and
false-negative detections. Imaris performed automated computation of spine density and
estimation of morphometric parameters for individual spines, including spine length,
terminal diameter, and volume.
Ex vivo slice preparation. All steps of electrophysiological experiments, including data
collection and analysis, were performed by a researcher blinded to genotype. Acute
hippocampal slices were prepared from mice 9 to 12 weeks of age. Animals were
anesthetized with isoflurane and transcardially perfused with ice-cold oxygenated (95%
O2, 5% CO2) cutting artificial cerebrospinal fluid (aCSF) solution (comprised of (mM): 2.5
KCl, 1.25 NaH2PO4, 5 MgSO4, 0.5 CaCl2, 200 sucrose, 25 NaHCO3, 25 glucose, ~300
mOsm, 7.2-7.4 pH). After decapitation, brains were removed for sectioning in the same
ice-cold cutting aCSF using a Vibratome (Leica Microsystems 1200S). For whole-cell
patch-clamp recordings of mE/IPSCs and the measurement of intrinsic membrane
properties, 350-μm transverse hippocampal sections were prepared. For all voltagesensitive dye experiments, 400-μm transverse hippocampal sections were prepared.
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Slices were recovered in the same cutting aCSF solution at 32 °C for 30 min and
transferred to an oxygenated room-temperature solution composed of 50% cutting aCSF
and 50% regular aCSF (comprised of (mM): 125 NaCl, 2.5 KCl, 1.25 NaH 2PO4, 10
glucose, 26 NaHCO3, 2 CaCl2, 1 MgCl2, ~300 mOsm, 7.2-7.4 pH) for 30 min.
Subsequently, slices were transferred to 100% regular aCSF at room temperature for an
additional 30 min before recording. All recordings were performed at 34 °C.
Intrinsic membrane properties. A pipette internal solution comprised of (mM): 130 Kgluconate, 6.3 KCl, 1 MgCl2, 0.5 EGTA, 10 HEPES, 4 MgATP, 0.3 NaGTP, 280-290
mOsm) was used. Input resistance was measured using 10 mV test pulses, in the
absence of any resistance compensation. An input-output curve was generated in
current-clamp mode using 300-ms constant-current steps of increasing intensity (0-120
μA at 20-μA intervals) and counting the number of action potentials during the time
window. Spike threshold (action potential threshold) was determined in current-clamp
mode using depolarizing current steps in 10 pA increments until single action potentials
were elicited, and the threshold voltage was determined as the membrane potential at
the beginning of the sharp upward rise of the depolarizing phase of the action potential.
mEPSCs. A pipette internal solution comprised of (mM): 140 KCH3OSO3, 5 KCl, 0.5
EGTA, 1 MgCl2, 10 HEPES, 5 MgATP, 0.25 NaGTP, ~292 mOsm, ECl = -78.8 mV was
used. Pipettes 4-6 MΩ in resistance were pulled from borosilicate glass capillaries
(World Precision Instruments, 1B150F-4) on a Sutter Instruments P-1000 pipette puller.
Voltage-clamp traces 5 min in duration were recorded at a holding potential of -70 mV in
the presence of 1 μM tetrodotoxin (Tocris). All recordings were conducted with access
resistance of less than 20 MΩ, leak current of less than 100 pA, and an applied series
resistance compensation of 80%. Cells that did not maintain these parameters for the
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duration of the recording were eliminated. Analysis of mEPSCs was performed using
pCLAMP10 (Axon Instruments, Molecular Devices) using a variable-amplitude template
method, generated from a stable recording of at least 50 mEPSC events. Each trace
was first low-pass filtered at 1 kHz, and negative-going mEPSCs were detected using a
template match threshold of 4, without fitting.
mIPSCs. In order to record mIPSCs while maintaining a hyperpolarized membrane
voltage, a high-chloride pipette internal solution (comprised of (mM): 100 CsCH 3O3S, 50
CsCl, 10 HEPES, 0.2 BAPTA, 3 KCl, 1 MgCl 2, 0.25 GTP-Tris, 2.5 creatine phosphate
disodium, 2 MgATP, ~296 mOsm, ECl = -23.7 mV) was used. Pipettes 4-6 MΩ in
resistance were pulled from borosilicate glass capillaries (World Precision Instruments,
1B150F-4) on a Sutter Instruments P-1000 pipette puller. Voltage-clamp traces 3 min in
duration were recorded at a holding potential of -70 mV in the presence of 1 μM
tetrodotoxin (Tocris) and 2 mM kynurenic acid (Sigma Aldrich). All recordings were
conducted with access resistance of less than 20 MΩ, leak current of less than 100 pA,
and an applied series resistance compensation of 80%. Cells that did not maintain these
parameters for the duration of the recording were eliminated. Analysis of mIPSCs was
performed using pCLAMP10 (Axon Instruments, Molecular Devices) using a variableamplitude template method, generated from a stable recording of at least 50 mIPSC
events. Each trace was first low-pass filtered at 1 kHz, and negative-going mIPSCs were
detected using a template match threshold of 4, without fitting.
Evoked AMPA/NMDA currents. A pipette internal solution (comprised of (mM): 125
CsCH3O3S, 4 NaCl, 1 EGTA, 10 HEPES, 4 MgATP, 0.3 NaGTP, 10 creatine phosphate
disodium, 0.1 spermine tetrahydrochloride) was used. A concentric bipolar tungsten
microelectrode was used for stimulation of the Schaffer collaterals. To normalize the
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stimulus intensity for evoked currents, the minimal stimulus to achieve a threshold
evoked response was first determined. Subsequently, a stimulus twice the intensity of
the minimal stimulus was used to elicit evoked currents. Voltage-clamp traces were
recorded at a holding potential of -70 mV (for AMPA-EPSCs) or +40 mV (for NMDAEPSCs) in the presence of 50 μM picrotoxin (Tocris). For each cell, at least 10 trials
were averaged to obtain a representative response at each holding potential. The peak
EPSC amplitude at -70 mV was taken as the magnitude of the AMPA-EPSCs. To
estimate the NMDA-dependent contribution to the EPSC at +40 mV, the EPSC
amplitude at 75 ms post-stimulus was used. Control experiments using the selective
NMDA antagonist D-AP5 confirmed that at 75 ms, the AMPA-dependent contribution to
the EPSC at +40 mV is very small compared to the NMDA-dependent contribution. To
calculate the NMDA/AMPA ratio, the magnitude of the NMDA-dependent component at
+40 mV was divided by the peak amplitude of the AMPA-EPSC at -70 mV.
Extracellular field recordings. Pipettes 2-4 MΩ in resistance were pulled from
borosilicate glass capillaries (World Precision Instruments, 1B150F-4) on a Sutter
Instruments P-1000 pipette puller and filled with regular aCSF. Recordings were
conducted in the stratum radiatum of CA1, 400-500 μm from the site of stimulation. For
stimulation of the Schaffer collateral pathway, a concentric bipolar stimulation electrode
(World Precision Instruments) was placed in stratum radiatum at the CA3-CA1 junction.
The half-maximal stimulus intensity was determined for each slice by generating a
standardized curve using stimuli of increasing intensity (0-200 μA) and approximating
the minimum intensity that elicited the half-maximal fEPSP amplitude. The peak
amplitude of the presynaptic fiber volley preceding the field EPSP, measured from
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baseline, was used as an approximation of the number of fibers recruited by a given
stimulus.
Paired-pulse ratios. Two successive stimuli with a 60-ms interval were applied at the
approximate half-maximal stimulus intensity. An average trace from five trials was
generated for each slice. The paired-pulse ratio was calculated as the amplitude of the
second EPSP divided by the amplitude of the first EPSP.
Voltage-sensitive dye imaging. Following recovery, each slice was bulk-loaded with
100 μL of a solution containing the voltage-sensitive dye di-2-ANEPEQ (Antić and
Zecević, 1995; Habib-E-Rasul Mullah et al., 2013) (JPW1114, Molecular Probes) diluted
at 0.05 mg/mL in aCSF. Each slice was stained for 14 min, washed with aCSF, and
imaged in an interface chamber using an 80x80 CCD camera recording with a 1 kHz
frame rate (NeuroCCD; RedShirt Imaging). Illumination was provided by a 530 nm
Green LED (Thor Labs, M530L3-C2). A filter set (Chroma Technologies 11007v2 wide
Green) was used to allow excitation at 510-560 nm and collection of emitted
fluorescence at a wavelength >592 nm. Trials lasted 1000 ms each, with a 20 s inter-trial
interval. Interleaved trials without stimulation allowed for background subtraction.
All data analysis was performed in IGOR (Wavemetrics) on the average of 12
trials. Data were displayed as the change in fluorescence divided by the resting
fluorescence (ΔF/F). Regions of interest (ROIs) were drawn proximal (0-270 μm) and
distal (270-540 μm) to the site of stimulation, with the following approximate dimensions
(in pixels): 30x30 for stratum radiatum and 15x30 for stratum pyramidale/oriens. Like
other dyes of the ANEPP family, di-2-ANEPEQ decreases in fluorescence upon
membrane depolarization. To be consistent with electrophysiological conventions,
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depolarizing ΔF/F signals were displayed as upward signals (warmer colors) and
hyperpolarization ΔF/F signals were displayed as downward signals (colder colors).
Snapshots of VSDI represent a 70x70 pixel trimmed window, corresponding to an
approximately 635x635 μm field of view.
Statistical analyses. On the basis of previously published CDKL5 mouse models, we
chose similar sample sizes for all behavioral experiments performed. For assays other
than behavior, we determined approximate sample size and power from effect sizes
found in related models of neurodevelopmental disorders. Importantly, the number of
mice used for each experiment were pre-determined prior to the start of the experiment.
For behavioral assays, statistical analyses were performed using Prism
(GraphPad). All data sets were analyzed using the D’Agostino-Pearson omnibus test for
normality. Data sets with normal distributions were analyzed for significance using
unpaired Student’s two-tailed t-test. Data sets with non-normal distribution were
analyzed using the Mann-Whitney test. Two-way repeated measures ANOVA was
conducted for the appropriate data sets with Holm-Sidak’s multiple comparison test,
using adjusted *p<0.05.
All other assays that involved sub-sampling of animals were analyzed using R
(The R Project for Statistical Computing). Each data set was analyzed using a “linear
mixed effect model,” where Genotype was modeled as a fixed effect term and Animal
was modeled as a random effect term. This model accounts for both between-animal
and between-cell variation. For each assay, null and alternative models were
constructed using the lmer function in the lme4 package (Bates et al., 2015) in the
following format:
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m0 = lmer(Outcome ~ (1 | Animal), REML=TRUE)
m1 = lmer(Outcome ~ Genotype + (1 | Animal), REML=TRUE)
For data sets involving a third term (e.g. time), the following null and alternative models
were constructed, in order to test the significance of an interaction between Genotype
and the third term:
m0 = lmer(Outcome ~ Time + Genotype + (1 | Animal), REML=TRUE)
m1 = lmer(Outcome ~ Time*Genotype + (1 | Animal), REML=TRUE)
To make statistical comparisons, the KRmodcomp function from the pbkrtest package
(Halekoh and Højsgaard, 2014) was used:
KRmodcomp(m0, m1)
The KRmodcomp function reports a modified F-test statistic based on the Kenward and
Roger approximation (Kenward and Roger, 1997), which accounts for the small sample
sizes in our study, modified numerator and denominator degrees of freedom, and a pvalue. The estimated effect of Genotype is obtained from the alternative model
constructed using the lmer function from lme4.
For post-hoc comparisons of VSDI time point data, we used the glht function
from the multcomp package (Hothorn et al., 2008), with the p-values adjusted for
multiple comparisons using Holm’s method:
summary(glht(m1, linfct = K %*% X), test = adjusted(type = “holm”))
where the argument for linfct is a matrix of coefficients representing the linear
hypotheses to be tested. For voltage-sensitive dye imaging data, a total of six between40

Genotype comparisons were made, corresponding to six pre-selected time points poststimulus (0/8/10/20/40/60 ms). For each test, the z score and adjusted p-value are
reported.
For the analysis of cumulative distributions (mEPSC and mIPSC inter-event
intervals and amplitudes), all samples from each individual cell was sorted, binned, and
averaged at percent intervals, effectively generating a binned cumulative distribution
curve for each cell. Data from all cells of a given genotype were plotted at these distinct
binned percent intervals with the mean and error bars indicating s.e.m. The results were
analyzed using linear mixed effect models, incorporating a third term, “cumulative
frequency bin.” In two experiments (mEPSCs, AMPA/NMDA-EPSCs), Grubbs’ test for
outliers was applied with a threshold of p<0.01 on both wild type and mutant data sets,
with the excluded value noted in the figure legends.
All graphs are plotted using Prism (GraphPad). In our figures, p-values between
0.05 and 0.1 are shown explicitly, and the symbol * is used to denote all p-values less
than 0.05.
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Figures

Figure 1. Generation of Nex-cKO mice and validation of conditional knockout
strategy.
(A) Schematic of targeting construct, expression pattern of Nex-Cre (Goebbels et al.,
2006), and the Cre-dependent excision of exon 6 of a floxed Cdkl5 allele. Nex-cKO
(Nex-Cre; Cdkl5flox/y) male mice have a selective deletion of CDKL5 in forebrain
glutamatergic neurons. (B) Because of the lack of a suitable antibody for CDKL5
immunohistochemistry, western blotting was used to validate the cell type-specificity of
knockout. In the cortex and hippocampus, brain regions enriched in glutamatergic
neurons, CDKL5 levels are significantly reduced. In the striatum and cerebellum, where
Nex-Cre expression is low, CDKL5 levels are not grossly altered. GAPDH was used as
loading control in this panel. (C) CDKL5 protein levels are reduced by about 85% in
whole hippocampal lysates of Nex-cKO mice. -actin was used as loading control in this
panel. Mann-Whitney test, n=4 mice for WT, n=4 mice for Nex-cKO. Data are mean ±
s.e.m., *p<0.05.
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Figure 2. Assessment of home-cage locomotion, anxiety-related behavior, motor
coordination, olfaction, repetitive behavior, nesting, and hind limb clasping in
Nex-cKO mice.
(A) Nex-cKO mice exhibit unaltered locomotor activity during a 30-minute exploration of
a home cage-like environment. (Two-way RM ANOVA, n=13 mice for WT, n=25 mice for
Nex-cKO). (B) In the elevated zero maze, Nex-cKO and WT mice spend similar times in
open arms, demonstrating unaltered anxiety-related behavior. (unpaired t-test, n=28
mice for WT, n=34 mice for Nex-cKO). (C) In the Rotarod assay, Nex-cKO and WT mice
exhibit similar latencies to fall and improvement over multiple trials, demonstrating
unaltered motor coordination and learning. (Two-way RM ANOVA, n=27 mice for WT,
n=30 mice for Nex-cKO). (D) In the olfactory habituation-dishabituation test, Nex-cKO
and WT mice spend similar times sniffing various odors, demonstrating an intact
preference for social over non-social scents. Nex-cKO and WT mice also demonstrate
similar levels of habituation after repeated exposures to the same scent. (Two-way RM
ANOVA, n=9 mice for WT, n=14 mice for Nex-cKO). (E) Nex-cKO and WT mice exhibit
similar levels of repetitive behavior (grooming or digging) in a home cage-like
environment. (Mann-Whitney test, n=9 mice for WT, n=10 mice for Nex-cKO). (F) NexcKO and WT mice achieve similar scores in the nest building assay. (Mann-Whitney test,
n=9 mice for WT, n=8 mice for Nex-cKO). (G) Image of a P120 Nex-cKO mouse
suspended by the tail, exhibiting limb clasping. WT mice consistently splay their hind
limbs outward in anticipation of landing. In contrast, Nex-cKO mice exhibit clasping of
the hind limbs and sometimes also fore limbs. In a cohort of P120 mice, 0/11 of WT mice
and 17/18 (94%) of Nex-cKO mice exhibited limb clasping. The phenotype of limb
clasping begins to emerge in Nex-cKO mice at approximately P90. Data are mean ±
s.e.m.
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Figure 3. Unaltered sociability in Nex-cKO mice.
(A) WT and Nex-cKO mice did not exhibit a preference for either chamber during
habituation (phase I) of the three-chambered social approach assay, when no stimulus
mouse was present. (B) Similar to WT, Nex-cKO exhibited a strong preference for the
social chamber during social choice (phase II) of the three-chambered social approach
test. (C) Compared to WT, Nex-cKO mice exhibited similar levels of direct interaction
with the stimulus mouse. (D) WT and Nex-cKO mice exhibit similar levels of activity
during habituation, but Nex-cKO mice become hyperactive during the social choice
phase. Mann-Whitney test for all experiments. WT, n=28 mice; Nex-cKO, n=35 mice.
Data are mean ± s.e.m., *p<0.05.

44

Figure 4. Impaired hippocampal-dependent learning and memory in Nex-cKO
mice.
(A) Compared to wild type (WT) littermates, Nex-cKO mice showed decreased
spontaneous alternation on the Y-maze assay (unpaired t-test, n=20 mice for WT and
n=23 mice for Nex-cKO). (B) During the Y-maze assay, Nex-cKO mice make a greater
number of total entries into arms (unpaired t-test). (C, D) During both the forward (C) and
reversal (D) probe trials of the Barnes maze assay, Nex-cKO mice made more errors
before reaching the target hole (forward probe: unpaired t-test; reversal probe: MannWhitney test; n=9 mice for WT and n=19 mice for Nex-cKO). (E) During the reversal
probe trials of the Barnes maze assay, Nex-cKO mice also made more incorrect visits
(perseverations) to the previous escape hole (unpaired t-test). Data are mean ± s.e.m.,
*p<0.05.
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Figure 5. Decreased dendritic complexity in CA1 pyramidal neurons of Nex-cKO
mice.
(A) Representative tracings of neurons from WT and Nex-cKO mice. Scale bar indicates
50 μm. (B) Decreased branching of the basal dendritic tree in Nex-cKO mice. (C)
Decreased branching of proximal apical dendrites in Nex-cKO mice. (B-C) Linear mixed
effect model analysis, interaction of genotype and distance from soma, random effect of
animal. (D) A trend toward decreased total basal dendritic length in Nex-cKO mice. (E)
Similar total apical dendritic length between WT and Nex-cKO mice. (D-E) Linear mixed
effect model analysis, fixed effect of genotype, random effect of animal. For all dendritic
branching analysis, n=22 cells/3 mice for WT and n=24 cells/4 mice for Nex-cKO. Data
are mean ± s.e.m., *p<0.05.
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Figure 6. Analysis of spine density and morphology in CA1 pyramidal neurons of
Nex-cKO mice.
(A, D) Representative segments from basal and proximal apical (excluding the apical
tuft) dendrites of WT and Nex-cKO mice. Scale bar indicates 5 μm. (B) Similar spine
density at basal dendrites in Nex-cKO mice. (C) A trend toward increased spine volume
at basal dendrites in Nex-cKO mice. (E) A trend toward increased spine density at
proximal apical dendrites in Nex-cKO mice (F) Similar spine volume at proximal apical
dendrites in Nex-cKO mice. (B,C,E,F) Linear mixed effect model analysis, fixed effect of
genotype, random effect of animal. For all spine analysis, one dendritic segment was
imaged per cell. For basal dendritic spines, n=35 cells/3 mice for WT, n=47 cells/3 mice
for Nex-cKO. For proximal apical dendritic spines, n=34 cells/3 mice for WT and n=51
cells/3 mice for Nex-cKO). Data are mean ± s.e.m.
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Figure 7. Unaltered intrinsic membrane properties in CA1 pyramidal neurons of
Nex-cKO mice.
(A) Unaltered spike threshold in Nex-cKO mice. (B) Unaltered input resistance in NexcKO mice. (A-B) Linear mixed effect model analysis, fixed effect of genotype, random
effect of animal. (C) Unaltered input-output curve in Nex-cKO mice. For the input-output
curve, incremental 300 ms current steps were applied, and the number of spikes was
counted for each current amplitude. (C) Linear mixed effect model analysis, interaction
of genotype and current injected, random effect of animal. For all intrinsic membrane
property experiments: n=18 cells/4 mice for WT and n=24 cells/3 mice for Nex-cKO.
Data are mean ± s.e.m.
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Figure 8. Increased mEPSC frequency in CA1 pyramidal neurons of Nex-cKO
mice.
(A) Representative traces of mEPSCs recorded from WT and Nex-cKO mice. (B) A trend
toward increased frequency of mEPSCs in Nex-cKO mice. (C) Decreased inter-event
interval of mEPSCs in Nex-cKO mice. (D-E) Unaltered mEPSC amplitude in Nex-cKO.
(F) Unaltered mEPSC 10-90% rise time in Nex-cKO mice. (G) Unaltered mEPSC 9010% decay time in Nex-cKO mice. (H) Unaltered mEPSC charge transfer rate in NexcKO mice. (B, D, F, G, H) Linear mixed effect model analysis, fixed effect of genotype,
random effect of animal. (C, E) Linear mixed effect model analysis, interaction of
genotype and cumulative frequency bin, random effect of animal. For all mEPSC
analysis, one data point (WT, mEPSC frequency = 3.95 Hz) was eliminated in Grubb’s
test for outliers (p<0.01); n=18 cells/3 mice for WT and n=19 cells/3 mice for Nex-cKO.
Data are mean ± s.e.m. *p<0.05.
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Figure 9. Unaltered AMPA/NMDA ratio in CA1 pyramidal neurons of Nex-cKO mice.
(A) Representative evoked AMPA-dependent EPSCs recorded at -70 mV. (B)
Representative evoked compound EPSCs recorded at +40 mV. Dotted line indicates 75
ms post-stimulus, a time point at which the AMPA-dependent contribution is considered
negligible. (C) Similar amplitudes of AMPA-dependent EPSCs recorded at -70 mV. (D)
Similar amplitudes of NMDA-dependent component of EPSCs. (E) Unaltered
NMDA/AMPA ratio in Nex-cKO mice. (C, D, E) Linear mixed effect model analysis, fixed
effect of genotype, random effect of animal. One data point (WT, AMPA-EPSC = 305.1
pA) was eliminated in Grubb’s test for outliers (p<0.01). n=21 cells/4 mice for WT and
n=22 cells/4 mice for Nex-cKO. Data are mean ± s.e.m.
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Figure 10. Increased mIPSC frequency in CA1 pyramidal neurons of Nex-cKO
mice.
(A) Representative traces of mIPSCs recorded from WT and Nex-cKO mice. (B) A trend
toward increased frequency of mIPSCs in Nex-cKO mice. (C) Decreased inter-event
interval of mIPSCs in Nex-cKO mice. (D-E) Unaltered mIPSC amplitude in Nex-cKO
mice. (F) Unaltered mIPSC 10-90% rise time in Nex-cKO mice. (G) Increased mIPSC
90-10% decay time in Nex-cKO mice. (H) Increased mIPSC charge transfer rate in NexcKO mice. (B, D, F, G, H) Linear mixed effect model analysis, fixed effect of genotype,
random effect of animal. (C, E) Linear mixed effect model analysis, interaction of
genotype and cumulative frequency bin, random effect of animal. For all mIPSC
analysis, n=18 cells/3 mice for WT and n=17 cells/3 mice for Nex-cKO. Data are mean ±
s.e.m., *p<0.05.
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Figure 11. Disrupted spatiotemporal dynamics of the CA1 microcircuit in Nex-cKO
mice
(A) Schematic of voltage-sensitive dye imaging (VSDI) showing the site of stimulation,
site of field EPSP recording, and regions of interest (ROIs) used for analysis. SR:
stratum radiatum; SP/SO: stratum pyramidale/oriens. Proximal and distal ROIs were
drawn for SR and SP/SO to assess the spatiotemporal spread of excitation and
inhibition. (B) Representative snapshots of Schaffer-evoked VSDI responses in WT and
Nex-cKO mice. Depolarization is represented by warm colors while hyperpolarization is
represented by cool colors. Pixels with ΔF/F changes of less than 1x10 -3 (approximately
3x the noise level) were blanked. Scale bars in (A) and (B) indicate 200 μm. (C)
Representative VSD responses in WT and Nex-cKO mice in the proximal and distal
SP/SO and SR. Following current-clamp convention, depolarization (decrease in ΔF/F)
is displayed as an upward signal, while hyperpolarization (increase in ΔF/F) is displayed
as a downward signal. A stimulus artifact occurring at 1-4 ms post-stimulation was
removed. (D-G) Averaged responses (ΔF/F) in stratum pyramidale/oriens (D, E) and
stratum radiatum (F, G) of WT and Nex-cKO slices during the 130 ms immediately
following Schaffer collateral stimulation. Note that excitation is enhanced in proximal, but
not distal regions, while inhibition is enhanced primarily in the SP/SO. Error envelopes
represent mean +/- s.e.m. For all experiments, n=19 slices/7 mice for WT and n=18
slices/5 mice for Nex-cKO.
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Figure 12. VSDI summary data, standardization of stimulus intensity, and pairedpulse ratio.
(A-D) Statistical comparisons of stratum pyramidale/oriens (A, B) and stratum radiatum
(C, D) responses in WT and Nex-cKO mice at specific time points following stimulation.
Note significantly enhanced excitation in Nex-cKO at 8-10 ms post-stimulus in proximal,
but not distal, SR and SP/SO. Note significantly enhanced inhibition in Nex-cKO in the
proximal and distal SP/SO at 40 ms and 20 ms post-stimulus, respectively. (A-D) Linear
mixed effect model analysis, interaction of genotype and time point, random effect of
animal. Generalized linear hypothesis tests were performed for individual time points
with Holm’s method to adjust for multiple comparisons. (E) Representative Schafferevoked field EPSP traces in WT and Nex-cKO mice recorded at incremental stimulus
intensity from 0-200 μa. The “half-maximal” stimulus intensity was defined as the
stimulus required to elicit approximately 50% of the maximal Schaffer-evoked field EPSP
amplitude in stratum radiatum. (F) Standardized half-maximal stimulus intensities used
for voltage-sensitive dye imaging were not significantly different between WT and NexcKO mice. (G) Fiber volley amplitudes elicited at half-maximal stimulus intensities were
not significantly different between WT and Nex-cKO mice. (H) Representative pairedpulse fEPSP responses from WT and Nex-cKO mice, elicited at half-maximal stimulus
intensity using a 60 ms inter-stimulus interval. (I) Paired-pulse ratios of field EPSPs were
not significantly different in WT and Nex-cKO mice. (F-I) Linear mixed effect model
analysis, fixed effect of genotype, random effect of animal. For all experiments, n=19
slices/7 mice for WT and n=18 slices/5 mice for Nex-cKO. Data are mean ± s.e.m.
*p<0.05.

56

Figure 13. Model of synaptic and circuit abnormalities in Nex-cKO mice.
In WT mice, the Schaffer collateral pathway predominantly activates excitatory synapses
in the proximal dendrites (stratum radiatum) of CA1 pyramidal neurons. Activation of
local interneurons leads to inhibition primarily in the cell body layer (stratum pyramidale).
In mice lacking CDKL5 selectively in excitatory neurons, the concomitant upregulation of
excitatory and inhibitory synaptic activity leads to exaggerated synaptic responses that
alter the spatiotemporal dynamics of the CA1 microcircuit.
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CHAPTER 3 – GABAERGIC NEURON DYSFUNCTION AND ALTERED
GLUTAMATERGIC SIGNALING UNDERLIE AUTISTIC-LIKE FEATURES IN CDKL5DEFICIENT MICE

Contributions: Sheng Tang led this study, with help from I-Ting Judy Wang and Barbara
Terzic for behavioral experiments, Cuiyong Yue and Hajime Takano for
electrophysiologic experiments, and Zhaolan Zhou and Douglas Coulter for the review
and interpretation of data. Yolanda Cui managed mouse colonies. Sheng Tang wrote
this chapter with input from all authors.

Abstract
CDKL5 deficiency disorder (CDD) is characterized by epilepsy, intellectual
disability, and autistic features. CDKL5-deficient mice exhibit a constellation of
behavioral deficits reminiscent of CDD, including impaired learning and memory and
social deficits. Previous studies have delineated the functions of CDKL5 in forebrain
glutamatergic neurons in regulating cellular morphology, synaptic transmission, and
learning and memory. However, the role of CDKL5 in GABAergic neurons remain
unknown. Here, we find that selective deletion of CDKL5 in forebrain GABAergic
neurons results in autistic-like features in mice. At the synaptic level, we discover a noncell autonomous enhancement of glutamatergic transmission that leads to circuit
hyperexcitability. Furthermore, acute reduction of glutamatergic transmission
ameliorates autistic-like features in CDKL5-deficient mice. Together, our findings
suggest that GABAergic dysfunction and network hyperexcitability underlie autistic-like
features in CDKL5-deficient mice and provide a novel therapeutic avenue to treat CDDrelated symptoms.
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Introduction
Mutations in cyclin-dependent kinase-like 5 (CDKL5) cause a severe
neurodevelopmental disorder characterized by seizures, intellectual disability, and
autistic features (Kalscheuer et al., 2003; Tao et al., 2004; Weaving et al., 2004). Mouse
models of (CDD) have recapitulated numerous aspects of the human disorder, showing
behavioral deficits such as impaired learning, reduced sociability, motor dysfunction, and
altered anxiety-related behavior (Amendola et al., 2014; Jhang et al., 2017; Okuda et al.,
2018; Wang et al., 2012). The extent to which these behavioral deficits arise from
common or distinct mechanisms, however, remain unclear.
CDKL5 protein expression is enriched in the forebrain, primarily in glutamatergic
and GABAergic neurons (Johnson et al., 2017; Wang et al., 2012; Zeisel et al., 2015). In
glutamatergic neurons, CDKL5 has been found at the postsynaptic density, where it
interacts with PSD-95 and NGL-1 (Ricciardi et al., 2012; Zhu et al., 2013). In addition,
loss of CDKL5, both in vitro and in vivo, has been associated with altered dendritic spine
density and morphology, altered excitatory synaptic transmission, and altered synaptic
plasticity (Okuda et al., 2017; Ricciardi et al., 2012; Sala et al., 2016; Tang et al., 2017).
At the behavioral level, mice lacking CDKL5 selectively in forebrain glutamatergic
neurons (Nex-cKO) show impaired learning and memory (Tang et al., 2017), reminiscent
of the intellectual disability found in CDD. Surprisingly, however, Nex-cKO mice did not
show other behavioral deficits found in Cdkl5 constitutive knockout mice, including
alterations in sociability, stereotypic behavior, locomotion, motor coordination, and
anxiety-related behavior (Tang et al., 2017). These results demonstrated the importance
of CDKL5 function in glutamatergic neurons for learning and memory, but also
suggested the potential roles of CDKL5 in other neuronal populations.
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Loss of CDKL5 has been associated with numerous functional changes at the
synaptic and circuit levels. A recent study found that CDKL5 knockout mice showed
increased susceptibility to NMDA-induced seizures and correspondingly, increased
NMDA-dependent synaptic transmission and enhanced long-term potentiation at
hippocampal synapses (Okuda et al., 2017). Interesting, Nex-cKO mice do not show a
selective enhancement of NMDA signaling but instead a non-specific increase in
glutamatergic synaptic transmission (Tang et al., 2017). Furthermore, Nex-cKO mice
show concomitant changes in synaptic inhibition that constrain hyperexcitability at the
circuit level. Taken together, the differences between Cdkl5 constitutive knockout mice
and Nex-cKO mice suggest that altered glutamatergic synaptic transmission may arise
from both cell autonomous and non-cell autonomous mechanisms. In addition, the
extent to which altered glutamatergic signaling underlies CDD-related behavioral
phenotypes remains unclear.
Here, we demonstrate that the loss of CDKL5 in forebrain GABAergic neurons
(Dlx-cKO) leads to autistic-like features in mice. Surprisingly, we find that excitatory
synaptic transmission is enhanced in a non-cell autonomous manner, with the relative
sparing of inhibitory synaptic transmission. Dlx-cKO mice also show hyperexcitability at
the circuit level, exhibiting aberrant paired-pulse facilitation at perforant path-dentate
gyrus synapses. In CDKL5-deficient mice, we find that acute, low-dose NMDAR
blockade selectively ameliorates autistic-like features, demonstrating that an excess of
glutamatergic synaptic transmission underlies selective behavioral deficits in CDD. Our
findings support a novel mechanism by which GABAergic neuron-specific loss of CDKL5
and altered glutamatergic signaling contribute to the etiology of autistic-like behaviors in
a mouse model of CDD.
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Results
Mice lacking CDKL5 in GABAergic neurons show autistic-like features
To investigate the role of CDKL5 in GABAergic neurons, we generated
conditional knockout mice lacking CDKL5 selectively in forebrain GABAergic neurons
(Dlx-cKO) using the Dlx-5/6 Cre driver (Fig. 1A, B) (Monory et al., 2006). Dlx-cKO mice
showed normal growth and body weight through adulthood and no obvious physical
abnormalities (Fig. 1C). We therefore performed a battery of behavioral assays, similar
to those in previous studies of Cdkl5 constitutive KO and Nex-cKO mice. Like Nex-cKO
mice, Dlx-cKO showed unaltered home-cage locomotion, anxiety-related behaviors, and
motor coordination (Fig. 2). We next assessed learning and memory, a behavioral
domain significantly impaired in both Cdkl5 constitutive knockout mice and Nex-cKO
mice. Unlike Nex-cKO mice, Dlx-cKO showed no impairment in spontaneous alternation
behavior on the Y-maze, suggesting intact working memory (Fig. 3A, B). On the Barnes
maze, an assay of spatial learning and memory, Dlx-cKO did not show a significant
difference from wild type controls in the number of errors made on probe trials (Fig. 3C).
However, when the target hole location was altered to the opposite side of the maze
(reversal probe trials) after acquisition, Dlx-cKO mice showed a significant impairment in
adjusting to this new target hole (Fig. 3D). Furthermore, Dlx-cKO mice also
demonstrated an increased number of perseverations on reversal probe trials, or visits to
the previous target hole location (Fig. 3E). These results suggest that although Dlx-cKO
mice are comparable to wild type controls in several learning and memory assays, they
demonstrate signs of cognitive inflexibility, a phenotype reminiscent of autism spectrum
disorders.
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On the three-chamber social approach assay, Dlx-cKO mice demonstrated
significantly altered social behavior, showing a lack of preference for investigating a
social stimulus as compared to an object (Fig. 4A, B). When allowed the opportunity for
direct interaction with a novel stimulus mouse, Dlx-cKO mice also spent significantly less
time initiating contact in comparison to wild type controls (Fig. 4C). To rule out the
involvement of an olfactory deficit underlying reduced social preference, we conducted
the olfactory habituation-dishabituation test. Dlx-cKO mice showed intact ability to
discriminate between different scents and also habituated to repeated presentation of
the same scent. Interestingly, however, Dlx-cKO mice showed reduced time sniffing a
social scent, consistent with a reduced interest in social stimuli (Fig. 4D).
In addition to social behaviors, we also assessed stereotypic behaviors, another
feature of autism spectrum disorder. In a home-cage like environment, Dlx-cKO mice
showed significantly increased time engaging in stereotypic behaviors such as grooming
and digging (Fig. 4E), and also exhibited a nesting deficit, considered by some to be a
home-cage social behavior (Fig. 4F). Taken together, Dlx-cKO mice show a set of
autistic-like features with relatively preserved learning and memory that stand in contrast
to previous findings in Nex-cKO mice, which show selectively impaired learning and
memory. These results demonstrate a segregation of behavioral deficits in Cdkl5
conditional knockout mice, suggesting that impaired learning and autistic-like features
have distinct cellular origins in CDD.
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Dlx-cKO mice show a non-cell autonomous enhancement of excitatory synaptic
transmission
Although several functions of CDKL5 in excitatory neurons have been described,
the role of CDKL5 in regulating inhibitory synaptic transmission is largely unknown.
Given that CDKL5 protein is expressed in diverse populations of GABAergic neurons,
we first assessed inhibitory synaptic transmission onto pyramidal neurons in the
hippocampal CA1 region, which receive input from multiple GABAergic interneuron
types. Surprisingly, recordings of miniature spontaneous inhibitory postsynaptic currents
(mIPSCs) did not reveal significant differences in either amplitude, frequency, or kinetics
between Dlx-cKO and wild type controls (Fig. 5A-F), suggesting that in adult Dlx-cKO
mice, any alteration of inhibitory signaling directly onto pyramidal neurons is likely subtle.
In contrast, when we examined excitatory neuron-to-excitatory neuron synaptic
transmission through the recording of miniature spontaneous excitatory postsynaptic
currents (mEPSCs) at CA1 pyramidal neurons, we found a significant enhancement of
mEPSC frequency, but not amplitude, in Dlx-cKO mice (Fig. 6A-F). This finding suggests
that as a result of the loss of CDKL5 in GABAergic neurons in mice, excitatory synaptic
transmission is enhanced in a non-cell autonomous manner.

Dlx-cKO mice show aberrant paired-pulse facilitation leading to circuit hyperexcitability
The finding of enhanced excitatory synaptic transmission with relative sparing of
inhibitory synaptic transmission suggests that Dlx-cKO mice may show hyperexcitability
at the circuit level. We therefore interrogated the function of the perforant path-dentate
gyrus pathway, a microcircuit that critically relies on both excitation and inhibition for
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proper function and is often perturbed in disease states (Coulter et al., 2011; Dengler
and Coulter, 2016; Goldberg and Coulter, 2013). Using voltage-sensitive dye imaging
(Carlson and Coulter, 2008) as a readout, we assessed the layer-specific responses of
the molecular layer, granule cell layer, as well as the downstream hilar region in
response to paired-pulse stimulation (Fig. 7). At the inter-stimulus interval tested, wild
type mice showed comparable responses to the first and second stimuli without
significant facilitation or depression, whereas Nex-cKO mice showed a trend toward
paired-pulse depression suggestive of circuit hypo-excitability (Fig. 7B-E). In contrast,
Dlx-cKO mice exhibited enhanced paired-pulse facilitation, evident by an increase in
depolarization upon a second successive stimulus (Fig. 7B-E). Furthermore, the
facilitating response in Dlx-cKO mice is propagated through the granule cell layer to the
downstream hilar region (Fig. 7A and data not shown). Taken together, these findings
suggest that Dlx-cKO mice, in contrast to wild type and Nex-cKO mice, show an aberrant
paired-pulse facilitation response that leads to circuit hyperexcitability upon repeated
stimulation.

Acute NMDAR blockade ameliorates autistic-like features in CDKL5-deficient mice
The finding of enhanced excitatory synaptic transmission and circuit
hyperexcitability in Dlx-cKO mice suggests that altered synaptic and circuit function may
underlie aspects of behavior in Cdkl5 constitutive knockout mice. A previous study found
that excitatory synaptic transmission involving NMDA, rather than AMPA receptors, is
selectively enhanced in Cdkl5 knockout mice (Okuda et al., 2017). We therefore
investigated the extent to which enhanced NMDA signaling is responsible for the
behavioral deficits in CDKL5-deficient mice. We conducted our assays in a newly
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generated Cdkl5 knock-in mouse line (R59X), which carries an early nonsense mutation,
mimicking a patient mutation, that results in the truncation of the catalytic domain of
CDKL5 (Fig. 8A). Similar to our previously generated exon 6-deletion (knockout) mouse
line, the R59X mutation was found to be a loss-of-function allele that led to the absence
of full-length functional CDKL5 protein (Fig. 8B).
We first tested the possibility that enhanced NMDAR signaling may underlie
impaired learning and memory in CDKL5-deficient mice. We used memantine, a noncompetitive NMDA receptor blocker that has been previously found to rescue behavioral
deficits in various mouse models of neurodevelopmental disorders (Chung et al., 2015;
Figueiredo et al., 2013; Kang and Kim, 2015). Using the Y-maze as a preliminary
screening assay, we found while R59X mice demonstrated a robust working memory
deficit, acute memantine administration at a range of doses did not ameliorate this
behavioral deficit (Fig. 9A). Notably, R59X mice also exhibit increased stereotypic
behavior, characterized by prolonged bouts of grooming (Fig. 9B, C). Acute memantine
administration significantly reduced both total time spent grooming and the duration of
the longest grooming bout of R59X mice to a level similar to that of wild type controls
(Fig. 9B, C). We also assessed social preference through a modified dyadic interaction
assay, a quantitative assay of the time spent in direct social interaction with a novel
stimulus mouse. Whereas vehicle-administered R59X mice showed significantly reduced
social interaction, memantine ameliorated this deficit, significantly increasing the time
spent by R59X mice in social interaction (Fig. 9D). This effect was specific to R59X
mice, as memantine normalized the ratio of time spent in social interaction in pairs of
R59X and wild type control mice co-tested side-by-side in identical cages (Fig. 9E).
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Taken together, these results suggest that enhanced NMDAR signaling underlies
autistic-like features, but not learning and memory deficits, in CDKL5-deficient mice.

Discussion
Segregation of behavioral deficits in Cdkl5 conditional knockout mice
Our behavioral studies in Dlx-cKO mice revealed a set of autistic-like features
characterized by reduced social preference and increased stereotypic behaviors, but
relative preservation of other behaviors such as learning and memory, motor
coordination, and anxiety-related behaviors. This behavioral profile stands in contrast to
our previous findings in Nex-cKO mice, which exhibit selectively impaired learning and
memory. Taken together, our results demonstrate a relative segregation of behavioral
phenotypes of the Cdkl5 constitutive knockout mice in Nex- and Dlx-cKO mice,
suggesting that impaired learning primarily originates from the loss of CDKL5 in
forebrain glutamatergic neurons, whereas autistic-like features primarily originate from
the loss of CDKL5 in forebrain GABAergic neurons. Several phenotypes of constitutive
knockout mice, including altered anxiety-related behavior, locomotion, and motor
coordination, were not altered in either Nex-cKO and Dlx-cKO mice. These additional
phenotypes may be mediated by 1) CDKL5 function in other cell populations and brain
regions and/or 2) the synergistic functions of CDKL5 in forebrain glutamatergic and
GABAergic neurons.
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Excitation-inhibition imbalance in Dlx-cKO mice
In our electrophysiologic studies of Dlx-cKO mice, the most prominent change
was, surprisingly, an enhancement in glutamatergic synaptic transmission. This change
likely arises from a non-cell autonomous mechanism, especially in the absence of a
concomitant change in GABAergic-glutamatergic inhibitory synaptic transmission. One
possible explanation is that the loss of CDKL5 in GABAergic interneurons lead to a
modulation of presynaptic release probability at glutamatergic synapses. A second
explanation is that a transient alteration of GABAergic signaling earlier in development
led to altered excitatory synaptogenesis, which persisted into adulthood. Interestingly,
previous studies have found that GABAergic transmission cooperates with NMDA
receptor activation during development for excitatory synapse formation (Wang and
Kriegstein, 2008).
At the circuit level, our findings in Dlx-cKO mice suggest an excitation-inhibition
imbalance that favors overall hyperexcitability. The paired-pulse stimulation paradigm
assesses, in a frequency-dependent manner, the integration of excitatory and inhibitory
synaptic transmission in the dentate gyrus and propagation to downstream regions.
Previous work has shown that NMDA signaling is a necessary component for the pairedpulse facilitation response in the dentate gyrus, suggesting a potential mechanism for
circuit excitability in Dlx-cKO mice (Joy and Albertson, 1993). Importantly, the response
in Dlx-cKO mice strongly contrasts with that of Nex-cKO mice, which showed a tendency
for paired-pulse depression and circuit hypo-excitability. Taken together, these results
support a model by which CDKL5 loss in glutamatergic and GABAergic neurons lead to
divergent changes in excitation-inhibition balance to generate distinct behavioral deficits.
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NMDAR signaling underlies several behavior deficits in CDKL5-deficient mice
The finding of enhanced NMDAR signaling revealed a novel synaptic mechanism
that may potentially underlie the behavioral deficits of CDKL5-deficient mice. Our results
suggest that the acute reduction of NMDAR signaling ameliorates some, but not all
features of CDD. Specifically, whereas acute memantine administration rescued
repetitive behavior and significantly improved social interaction in R59X mice, it did not
positively affect the learning and memory deficit of R59X mice. These results suggest
that the behavioral deficits of CDD may have origins in additional or distinct synaptic
mechanisms. For example, altered AMPA receptor-dependent synaptic transmission and
altered inhibitory synaptic transmission have both been previous reported in CDD.
Furthermore, subtypes of NMDA receptors, which are expressed in distinct patterns
across brain regions (Goebel and Poosch, 1999), may contribute differentially to various
behavioral deficits in CDKL5-deficient mice.
Taken together, our studies delineate the forebrain GABAergic origins of autisticlike features in CDKL5-deficient mice, showing for the first time that CDKL5 is required in
this diverse population of neurons for proper neural development and function. At the
synaptic and circuit levels, we reveal a non-cell autonomous mechanism that contributes
to hyperexcitability in CDKL5-deficient mice. Finally, we show that acute reduction of
NMDAR signaling can ameliorate certain behavioral deficits in CDKL5-deficient mice,
highlighting a potentially important mechanism for development of CDD-related
phenotypes in mice and supporting a novel therapeutic avenue for the treatment of these
symptoms in humans.
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Materials and Methods

The behavioral assay protocols here are identical to those described for the
study of Nex-cKO mice (Chapter 2), with additional protocols and details elaborated
below.
Mouse strains. The Cdkl5 floxed mouse line with Cre-dependent excision of
exon 6 (Tang et al. 2017) was used for the generation of conditional knockout mice.
Dlx5/6-Cre, a mouse line expressing Cre in forebrain inhibitory neurons (Monory et al.,
2006), was obtained from Jackson Laboratories (Stock No. 008199). The CDKL5 R59X
knock-in line was generated as follows: a targeting vector was designed to insert a frtflanked neomycin resistance (neo) cassette downstream of exon 5, and a single
nucleotide change of C to T, leading to a nonsense mutation at arginine 59 (R59X) of the
Cdkl5 gene. The construct was electroporated into C57BL/6N embryonic stem (ES)
cells. Correctly targeted ES cells were injected into BALB/c blastocysts and resulting
chimeric mice were bred with B6.Cg-Tg(ACTFLPe)9205Dym/J (Jackson Laboratories,
Stock No. 005703) to remove the neo cassette. Resulting offspring were bred to
C57BL/6J mice (Jackson Laboratories, Stock No. 000664) for at least 10 generations.
The R59X knock-in mouse line has been deposited at Jackson Laboratories (Stock No.
028856).
Mouse husbandry. Experiments were conducted in accordance with the ethical
guidelines of the National Institutes of Health and with the approval of the Institutional
Animal Care and Use Committee of the University of Pennsylvania. Cdkl5flox, Dlx5/6-Cre,
and R59X mice were backcrossed to C57BL/6 for at least 10 generations before
breeding for experiments. Mouse lines were genotyped using a PCR-based strategy,
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with their respective primer sequences and other details found on the Jackson
Laboratories website under the appropriate stock numbers listed above. Mice were
group-housed in cages of three to five in a 12-h light/dark cycle with food and water
provided ad libitum.
For breeding of Dlx-cKO and wild type control mice, each breeding cage
consisted of two homozygous female mice (genotype: Cdkl5flox/Cdkl5flox) and one male
mouse (genotype: Dlx5/6-Cre/+). Male littermates (genotypes: Cdkl5flox/y;+/+ and
Cdkl5flox/y; Dlx5/6-Cre) were weaned at 3 weeks of age and housed together, with all
experiments performed on age-matched adult mice between 9 and 12 weeks of age. For
some behavioral experiments, wild type control mice (genotype: Cdkl5flox/y;+/+) from
Nex-cKO breedings (Tang et al. 2017) were pooled with wild type control mice from DlxcKO breedings (genotype: Cdkl5flox/y;+/+).
For breeding of R59X and wild type control mice, each breeding cage consistent
of two heterozygous female mice (genotype: R59X/+) and one male mouse (genotype:
+/y). Male littermates (genotypes: R59X/y and +/y) were weaned at 3 weeks of age and
housed together, with all experiments performed on age-matched adult mice between 9
and 12 weeks of age.
Western blot. Adult male mice were sacrificed by cervical dislocation. After
decapitation, brains were removed and sectioned into 1 mm coronal slices using a
mouse brain matrix. Tissue was dissected from the somatosensory cortex, striatum,
hippocampus, and cerebellum and homogenized in lysis buffer containing 1% NP-40, pH
8.0. Protein concentration was measured using the Bradford assay and a total of 20 μg
protein was loaded for each lane. Primary antibodies used in this study are anti-N70

terminal CDKL5 (generated in Wang et al, 2012; diluted 1:500), anti-GAPDH (MA515738, Invitrogen; RRID: AB_10977387; diluted 1:1000), anti-EB2 (AB45767, Abcam,
diluted 1:1000). Secondary antibodies (Licor) are goat anti-rabbit IRDye 800CW (RRID:
AB_10796098) and donkey anti-rabbit IRDye 680RD (RRID: AB_10954442) at dilutions
of 1:10,000. Standard protocols were used for the Odyssey Infrared Imaging System for
visualization and quantification.
Behavioral assays. All animal behavioral studies were carried out blinded to
genotype. Mice were allowed to habituate to the testing room for at least 1 hour before
the test, and testing was performed at the same time of day. All animal behaviors were
performed on adult male mice at 9-12 weeks of age, and the analysis of behavioral data
was carried out by a researcher blinded to genotype.
Dyadic interaction. The dyadic interaction test is an abbreviated version of the
three-chambered assay to quantitatively assess the duration of direct social interaction
in two freely behaving mice. One week prior to the assay, male R59X and wild type
control mice were singly housed to increase the motivation for social interaction and
reduce aggression. Age-matched, novel, wild type male stimulus mice were grouphoused. On the day of the test, test and stimulus mice were acclimated to the room for 1
hour prior to the start of the assay. Following this period, each test mouse is placed
individually in a clear, round Plexiglass cage (Pinnacle Technology, Lawrence, Kansas,
USA) measuring 8 inches tall and 9.5 inches in diameter, with a thin layer of bedding.
Following 30 minutes of habituation in the cage, a novel, age-matched stimulus mouse
was placed into the cage, and the mice were allowed to freely interact under video
monitoring for 10 min. The total duration of social interaction initiated by the test mouse
in the first 2 minutes was scored, and this included oro-genital sniffing, oro-facial sniffing,
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close following, placing one or both paws on the stimulus mouse, or allogrooming of the
stimulus mouse. “Co-tested pairs” refer to side-by-side tests involving two littermate
R59X and wild type control mice, each interacting with a novel stimulus mouse in a
separate cage.
Drug administration. Mice were acclimated to daily intraperitoneal (i.p.)
injections of vehicle (saline) for three days prior to each set of behavioral assays. For
each behavioral cohort, the entire cohort was administered either vehicle or drug, with
the experimenter blinded to the genotypes of mice throughout. All animal behaviors were
performed on adult male mice at 9-12 weeks of age, and the analysis of behavioral data
was carried out by a researcher blinded to genotype. Vehicle and drug (memantine
hydrochloride, Tocris Biosciences, United Kingdom) were diluted in saline at 10 μL per
gram mouse body weight for administration. Vehicle or drug was administered 1 hour
prior to the start of each behavioral assay, and during this period, mice were allowed to
habituate in the room where the assay would be carried out.
Ex vivo slice preparation. All steps of electrophysiological experiments,
including data collection and analysis, were performed by a researcher blinded to
genotype. Acute hippocampal slices were prepared from mice 9 to 12 weeks of age.
Animals were anesthetized with isoflurane and transcardially perfused with ice-cold
oxygenated (95% O2, 5% CO2) cutting artificial cerebrospinal fluid (aCSF) solution
(comprised of (mM): 2.5 KCl, 1.25 NaH2PO4, 5 MgSO4, 0.5 CaCl2, 200 sucrose, 25
NaHCO3, 25 glucose, ~300 mOsm, 7.2-7.4 pH). After decapitation, brains were removed
for sectioning in the same ice-cold cutting aCSF using a Vibratome (Leica Microsystems
1200S). For whole-cell patch-clamp recordings of mE/IPSCs and the measurement of
intrinsic membrane properties, 350-μm transverse hippocampal sections were prepared.
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For all voltage-sensitive dye experiments, 400-μm transverse hippocampal sections
were prepared. Slices were recovered in the same cutting aCSF solution at 32 °C for 30
min and transferred to an oxygenated room-temperature solution composed of 50%
cutting aCSF and 50% regular aCSF (comprised of (mM): 125 NaCl, 2.5 KCl, 1.25
NaH2PO4, 10 glucose, 26 NaHCO3, 2 CaCl2, 1 MgCl2, ~300 mOsm, 7.2-7.4 pH) for 30
min. Subsequently, slices were transferred to 100% regular aCSF at room temperature
for an additional 30 min before recording. All recordings were performed at 34 °C.
mEPSCs. A pipette internal solution comprised of (mM): 140 KCH 3OSO3, 5 KCl,
0.5 EGTA, 1 MgCl2, 10 HEPES, 5 MgATP, 0.25 NaGTP, ~292 mOsm, ECl = -78.8 mV
was used. Pipettes 4-6 MΩ in resistance were pulled from borosilicate glass capillaries
(World Precision Instruments, 1B150F-4) on a Sutter Instruments P-1000 pipette puller.
Voltage-clamp traces 5 min in duration were recorded at a holding potential of -70 mV in
the presence of 1 μM tetrodotoxin (Tocris). All recordings were conducted with access
resistance of less than 20 MΩ, leak current of less than 100 pA, and an applied series
resistance compensation of 80%. Cells that did not maintain these parameters for the
duration of the recording were eliminated. Analysis of mEPSCs was performed using
pCLAMP10 (Axon Instruments, Molecular Devices) using a variable-amplitude template
method, generated from a stable recording of at least 50 mEPSC events. Each trace
was first low-pass filtered at 1 kHz, and negative-going mEPSCs were detected using a
template match threshold of 4, without fitting.
mIPSCs. In order to record mIPSCs while maintaining a hyperpolarized
membrane voltage, a high-chloride pipette internal solution (comprised of (mM): 100
CsCH3O3S, 50 CsCl, 10 HEPES, 0.2 BAPTA, 3 KCl, 1 MgCl 2, 0.25 GTP-Tris, 2.5
creatine phosphate disodium, 2 MgATP, ~296 mOsm, ECl = -23.7 mV) was used.
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Pipettes 4-6 MΩ in resistance were pulled from borosilicate glass capillaries (World
Precision Instruments, 1B150F-4) on a Sutter Instruments P-1000 pipette puller.
Voltage-clamp traces 3 min in duration were recorded at a holding potential of -70 mV in
the presence of 1 μM tetrodotoxin (Tocris) and 2 mM kynurenic acid (Sigma Aldrich). All
recordings were conducted with access resistance of less than 20 MΩ, leak current of
less than 100 pA, and an applied series resistance compensation of 80%. Cells that did
not maintain these parameters for the duration of the recording were eliminated.
Analysis of mIPSCs was performed using pCLAMP10 (Axon Instruments, Molecular
Devices) using a variable-amplitude template method, generated from a stable recording
of at least 50 mIPSC events. Each trace was first low-pass filtered at 1 kHz, and
negative-going mIPSCs were detected using a template match threshold of 4, without
fitting.
Voltage-sensitive dye imaging. Following recovery, each slice was bulk-loaded
with 100 μL of a solution containing the voltage-sensitive dye di-2-ANEPEQ (Antić and
Zecević, 1995; Habib-E-Rasul Mullah et al., 2013) (JPW1114, Molecular Probes) diluted
at 0.05 mg/mL in aCSF. Each slice was stained for 14 min, washed with aCSF, and
imaged in an interface chamber using an 80x80 CCD camera recording with a 1 kHz
frame rate (NeuroCCD; RedShirt Imaging). Illumination was provided by a 530 nm
Green LED (Thor Labs, M530L3-C2). A filter set (Chroma Technologies 11007v2 wide
Green) was used to allow excitation at 510-560 nm and collection of emitted
fluorescence at a wavelength >592 nm.
A concentric bipolar tungsten microelectrode was used for stimulation of the
perforant path. Two successive stimuli were applied with an inter-stimulus interval of 200
ms. Two stimulation intensities (200 μA and 400 μA) were used. Imaging trials lasted a
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total of 1000 ms each, with a 20 s inter-trial interval. Interleaved trials without stimulation
allowed for background subtraction.
All data analysis was performed in IGOR (Wavemetrics) on the average of 12
trials. Data were displayed as the change in fluorescence divided by the resting
fluorescence (ΔF/F). Regions of interest (ROIs) were drawn for the molecular layer of
the dentate gyrus, the dentate granule cell layer, and the hilus. Like other dyes of the
ANEPP family, di-2-ANEPEQ decreases in fluorescence upon membrane depolarization.
To be consistent with electrophysiological conventions, depolarizing ΔF/F signals were
displayed as upward signals (warmer colors) and hyperpolarization ΔF/F signals were
displayed as downward signals (colder colors). Snapshots of VSDI represent an 80x80
pixel window, corresponding to an approximately 1.7 x 1.7 mm field of view.
Statistical analyses. For behavioral assays involving Dlx-cKO mice, we chose
similar sample sizes for all behavioral experiments based on previous published studies
of Cdkl5 constitutive knockout mice (Wang et al. 2012) and Cdkl5 glutamatergic
conditional knockout mice (Tang et al. 2017). For behavioral assays involving drug
administration, we used saline-administered pilot cohorts to estimate effect sizes
required for detecting significant wild type-mutant differences and used similar samples
sizes for drug-administered cohorts. Importantly, the number of mice used were predetermined prior to the start of each experiment.
For behavioral assays, statistical analyses were performed using Prism
(GraphPad). All data sets were analyzed using the Shapiro-Wilk test for normality. Data
sets with normal distributions were analyzed for significance using unpaired Student’s
two-tailed t-test. Data sets with non-normal distribution were analyzed using the Mann75

Whitney test. Two-way repeated measures ANOVA or the Kruskal-Wallis test was
conducted for the appropriate data sets with Holm-Sidak’s multiple comparison test,
using adjusted *p<0.05.
All other assays that involved sub-sampling of animals were analyzed using R
(The R Project for Statistical Computing). Each data set was analyzed using a “linear
mixed effect model,” where Genotype was modeled as a fixed effect term and Animal
was modeled as a random effect term. This model accounts for both between-animal
and between-cell variation. For each assay, null and alternative models were
constructed using the lmer function in the lme4 package (Bates et al., 2015) in the
following format:
m0 = lmer(Outcome ~ (1 | Animal), REML=TRUE)
m1 = lmer(Outcome ~ Genotype + (1 | Animal), REML=TRUE)
For data sets involving a third term (e.g. cumulative frequency bin), the following null and
alternative models were constructed, in order to test the significance of an interaction
between Genotype and the third term:
m0 = lmer(Outcome ~ Bin + Genotype + (1 | Animal), REML=TRUE)
m1 = lmer(Outcome ~ Bin*Genotype + (1 | Animal), REML=TRUE)
To make statistical comparisons, the KRmodcomp function from the pbkrtest package
(Halekoh and Højsgaard, 2014) was used:
KRmodcomp(m0, m1)
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The KRmodcomp function reports a modified F-test statistic based on the Kenward and
Roger approximation (Kenward and Roger, 1997), which accounts for the small sample
sizes in our study, modified numerator and denominator degrees of freedom, and a pvalue. The estimated effect of Genotype is obtained from the alternative model
constructed using the lmer function from lme4.
Post-hoc testing for linear mixed effect models (e.g. at cumulative frequency
bins) was performed using the least-squares means method for multiple comparisons.
The lsmeans package was used (Lenth, 2016) on the alternative model generated by
lmer:
lsmeans(m1, pairwise ~ Genotype | Bin, mode='kenward-roger')
For the analysis of cumulative distributions (mEPSC and mIPSC inter-event
intervals and amplitudes), all samples from each individual cell was sorted, binned, and
averaged at percent intervals, effectively generating a binned cumulative distribution
curve for each cell. Data from all cells of a given genotype were plotted at these distinct
binned percent intervals with the mean and error bars indicating s.e.m. The results were
analyzed using linear mixed effect models, incorporating a third term, “cumulative
frequency bin.”
All graphs are plotted using Prism (GraphPad). In our figures, p-values between
0.05 and 0.1 are shown explicitly, * is used to denote all 0.01<p<0.05, ** for
0.001<p<0.01, *** for 0.0001<p<0.001, and **** for p<0.0001.
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Figures

Figure 1. Generation and validation of mice lacking CDKL5 selectively in forebrain
GABAergic neurons (Dlx-cKO).
(A) Schematic representing the generation of Dlx-cKO mice using a conditional exon 6floxed Cdkl5 mouse line (Tang et al., 2017) and the Dlx5/6-Cre driver (Monory et al.,
2006). (B) Validation of the cell type-specificity of CDKL5 protein knockout using
microdissected brain tissue. Dlx-cKO mice are compared to both WT and Nex-cKO
(forebrain glutamatergic conditional knockout mice) (Tang et al., 2017). In regions
enriched for glutamatergic neurons (e.g. cortex and hippocampus), Nex-cKO but not DlxcKO mice show a reduction in CDKL5 protein. In regions enriched for GABAergic
neurons (e.g. striatum), Dlx-cKO mice but not Nex-cKO mice show a reduction in CDKL5
protein. In other brain regions (e.g. cerebellum), neither Dlx-cKO nor Nex-cKO mice
show reductions in CDKL5 protein. Asterisk indicates non-specific band. (C) Unaltered
body weight of Dlx-cKO mice at various ages.
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Figure 2. Dlx-cKO mice show unaltered locomotion, anxiety-related behavior, and
motor coordination.
(A) Dlx-cKO mice show unaltered home-cage locomotion on the beam break assay. (B)
Dlx-cKO mice, show unaltered anxiety-related behavior, as assessed by the percent
time spent in open arms, on the elevated zero maze assay. (C) Dlx-cKO mice show
unaltered motor coordination and learning on the Rotarod assay.

79

Figure 3. Dlx-cKO mice show preserved learning and memory, but impaired
cognitive flexibility.
(A) Dlx-cKO mice show unaltered spontaneous alternation percentage in comparison to
WT mice (WT, n = 20; Dlx-cKO: n = 12; unpaired t-test, ns). (B) The total number of
entries made were not significantly different between Dlx-cKO and WT mice (unpaired
t-test, ns). (C) Dlx-cKO mice did not show a significant difference in the total number of
errors made on forward probe trials of the Barnes maze (WT, n = 18; Dlx-cKO: n = 14;
unpaired t-test, ns). (D) Dlx-cKO mice made significantly more errors on the reversal
probe trials of the Barnes maze (unpaired t-test, p = 0.025). (E) On the reversal probe
trials, Dlx-cKO mice also made significantly more perseverations, or visits to the original
target hole location (Mann-Whitney test, p = 0.0061).
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Figure 4. Dlx-cKO mice show reduced sociability, increased stereotypic behaviors
and impaired nesting.
(A) Dlx-cKO mice showed similar times spent interacting with empty cylinders during the
habituation phase of the three-chambered assay (WT, n = 28; Dlx-cKO, n = 26; unpaired
t-tests, ns). (B) In contrast to wild type control mice, which showed a significant
preference for interacting with the cylinder containing a social stimulus, Dlx-cKO mice
did not show a significant difference in time spent sniffing the social and non-social
cylinders (WT, Mann-Whitney test, p < 0.0001; Dlx-cKO, unpaired t-test, ns). (C) During
the direct interaction phase of the assay, Dlx-cKO mice also spent significantly reduced
time initiating social contact (Mann-Whitney test, p < 0.0001). (D) In the olfactory
habituation-dishabituation test, Dlx-cKO mice showed unaltered ability to discriminate
between odors and habituation to the same odor upon repeated presentation. However,
Dlx-cKO mice show a reduced time sniffing a social scent compared to WT (WT, n = 20;
Dlx-cKO, n = 14; two-way ANOVA with Holm-Sidak’s multiple comparisons test: effect of
trial, p < 0.0001; effect of genotype, p = 0.0035; effect of interaction, p < 0.0001). (E)
Dlx-cKO mice spent significantly increased duration engaging in repetitive behaviors,
including grooming and digging, in a home cage-like environment (WT, n = 18; Dlx-cKO,
n = 16; unpaired t-test, p = 0.0028). (F) Dlx-cKO mice show significantly reduced nesting
scores on the nesting assay (WT, n = 9; Dlx-cKO, n = 8; Mann-Whitney test, p = 0.0002).
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Figure 5. Unaltered inhibitory synaptic transmission at CA1 pyramidal neurons in
Dlx-cKO mice.
(A) Dlx-cKO mice show unaltered mIPSC frequency at CA1 pyramidal neurons (WT, n =
18 cells / 3 mice; Dlx-cKO, n = 18 cells / 3 mice; linear mixed effect analysis, effect of
genotype, ns). (B) The cumulative frequency distributions of mIPSC inter-event intervals
were not significantly different between Dlx-cKO and WT mice (linear mixed effect
analysis, effects of genotype and interaction, ns). (C) Dlx-cKO mice show unaltered
median 10-90% mIPSC rise times (linear mixed effect analysis, effect of genotype, ns).
(D) The median amplitude of mIPSCs is not significantly different between Dlx-cKO and
WT mice (linear mixed effect analysis, effect of genotype, ns). (E) The cumulative
frequency distributions of mIPSC amplitudes are not significantly different between DlxcKO and WT mice (linear mixed effect analysis, effects of genotype and interaction, ns).
(F) Dlx-cKO mice show unaltered median 90-10% decay times at mEPSCs (linear mixed
effect analysis, effect of genotype, ns).
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Figure 6. Dlx-cKO mice show a non-cell autonomous enhancement of excitatory
synaptic transmission.
(A) Dlx-cKO mice show significantly enhanced mEPSC frequency at CA1 pyramidal
neurons (WT, n = 18 cells / 3 mice; Dlx-cKO, n = 16 cells / 3 mice; linear mixed effect
analysis, effect of genotype, p = 0.034). (B) The cumulative frequency distribution of
mEPSC inter-event intervals is also significantly shifted in Dlx-cKO mice (linear mixed
effect analysis with least-square means post-hoc testing, effect of genotype, p = 0.096,
effect of interaction, p = 2.3 x 10 -10). (C) The median 10-90% rise time of mEPSCs is
unaltered in Dlx-cKO mice (linear mixed effect analysis, effect of genotype, ns). (D) The
mEPSC median amplitude is unaltered in Dlx-cKO mice (linear mixed effect analysis,
effect of genotype, ns). (E) The cumulative frequency distributions of mEPSC amplitudes
are not significantly different between Dlx-cKO and WT mice (linear mixed effect
analysis, effects of genotype and interaction, ns). (F) The median 90-10% decay times of
mEPSCs is unaltered in Dlx-cKO mice (linear mixed effect analysis, effect of genotype,
ns).
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Figure 7. Dlx-cKO mice show aberrant paired-pulse facilitation.
(A) Schematic of voltage-sensitive dye imaging (VSDI) showing the site of stimulation at
the perforant path and regions of interest (ROIs) used for analysis. ML: molecular layer
of the dentate gyrus; GCL: dentate granule cell layer; HIL: hilar region. Averaged VSDI
responses in response to a pair of stimuli (200 μa intensity, 200 ms inter-stimulus
interval) in the respective layers. Following current-clamp convention, depolarization
(decrease in ΔF/F) is displayed as an upward signal, while hyperpolarization (increase in
ΔF/F) is displayed as a downward signal. Error envelopes represent mean +/- s.e.m. (B)
Zoomed-in views of peak VSDI responses of the GCL in WT, Nex-cKO and Dlx-cKO
mice. (C) Peak amplitudes of the response to the first stimulus were not different
between WT, Nex-cKO, and Dlx-cKO mice (linear mixed effect analysis, ns). (D) Peak
amplitudes of the response to the second stimulus were significantly different between
Nex-cKO and Dlx-cKO mice (linear mixed effect analysis with Tukey’s correction for
multiple comparisons: overall, p = 0.024; Nex-cKO vs Dlx-cKO, p = 0.021). (E) Ratios of
peak amplitudes were significantly different between Nex-cKO and Dlx-cKO mice (linear
mixed effect analysis with Tukey’s correction for multiple comparisons: overall, p =
0.012; Nex-cKO vs Dlx-cKO, p = 0.0092). For all experiments, n=20 slices/5 mice for
WT, n = 12 slices / 4 mice for Nex-cKO, and n = 19 slices / 5 mice for Dlx-cKO.
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Figure 8. Generation of CDKL5 R59X knock-in mice.
(A) Schematic of the R59X non-sense mutation at arginine 59, which results in early
truncation of the catalytic domain of CDKL5. (B) Validation of CDKL5 protein loss in
R59X and wild type control male mice. Western blots of dissected whole cortex lysate in
WT and R59X mice. Green arrow indicates band corresponding to CDKL5 protein. Total
EB2 protein was used as a loading control.
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Figure 9. Acute NMDAR blockade ameliorates autistic-like features, but not
learning and memory, in CDKL5-deficient mice.
(A) Spontaneous alternation percentage is significantly reduced in saline-treated R59X
mice in comparison to WT mice. However, acute memantine administration at either 2.5
or 5 mg/kg doses did not significantly rescue the spontaneous alternation deficit (WTsaline, n = 9; R59X-saline, n = 11; WT-memantine (5 mg/kg), n = 6; R59X-memantine (5
mg/kg), n = 6; WT-memantine (2.5 mg/kg), n = 6; R59X-memantine (2.5 mg/kg), n = 6;
Kruskal-Wallis test with Dunn’s multiple comparisons test, p = 0.014; WT-saline vs
R59X-saline, p = 0.0027). (B) Total grooming in a home cage-like environment is
significantly increased in saline-treated R59X mice in comparison to WT, and memantine
at 5 mg/kg significantly ameliorated the increased grooming phenotype in R59X mice (n
= 8 for all groups; one-way ANOVA with Holm-Sidak’s multiple comparisons test, WTsaline vs R59X-saline, p < 0.0001; R59X-saline vs R59X-memantine, p < 0.0001). (C)
The duration of the longest grooming bout is significantly increased in saline-treated
R59X mice in comparison to WT, and memantine also ameliorated this aspect of
repetitive behavior (n = 8 for all groups; one-way ANOVA with Holm-Sidak’s multiple
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comparisons test, WT-saline vs R59X-saline, p < 0.0001; R59X-saline vs R59Xmemantine, p < 0.0001). (D) On the dyadic social assay, saline-treated R59X mice
spend significantly less time initiating social interaction with a novel stimulus mouse in
comparison to WT. Memantine at 5 mg/kg resulted in a significant increase in time spent
in social interaction (n = 7 for all groups; one-way ANOVA with Holm-Sidak’s multiple
comparisons test, WT-saline vs R59X-saline, p = 0.0006; R59X-saline vs R59Xmemantine, p = 0.027). (E) For co-tested pairs of R59X and WT mice, the ratio of time
spent in direct interaction was significantly reduced in saline-treated mice. Memantine
normalized this ratio, indicating a differential effect of this drug on social interaction in
WT and R59X mice (n=7 for all groups; unpaired t-test, p = 0.0002).
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CHAPTER 4 – CDKL5 REGULATES THE ELABORATION OF THE DENDRITIC TREE
IN ADULT MICE

Contributions: Sheng Tang led this study, with help from Katarina Pance, Nicolas
Sarmiento, and Barbara Terzic for the analysis of data, and Zhaolan Zhou and Douglas
Coulter for the review and interpretation of data. Yolanda Cui managed mouse colonies.
Sheng Tang wrote this chapter with input from all authors.

Abstract
The formation and patterning of dendrites provide the structural basis of neural
circuit development and are critical for proper brain function. A single pyramidal neuron
has a dendritic tree that contains up to thousands of dendritic spines, which represent
the primary sites of excitatory synapses. Although much is known about the processes
that regulate dendritic outgrowth and synapse formation during early development, far
less is understood about the processes that regulate neuronal morphology in the adult
brain. Here, we show that the loss of cyclin-dependent kinase-like 5 (CDKL5) in mice
leads to a dendritic arborization deficit that is not apparent during early postnatal
development, but instead emerges in adulthood. Specifically, CDKL5-deficient mice fail
to show a continued elaboration of the dendritic tree from the juvenile period through
adulthood, in contrast to what is observed in wild type mice. Interestingly, this dendritic
arborization deficit was not accompanied by a change in dendritic spine density.
Together, our results support a novel role for CDKL5 in the elaboration and patterning of
the dendritic tree in the adult mouse brain and provide an intriguing example of impaired
dendritic stability in a model of CDKL5 deficiency disorder.
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Introduction
In early development, the outgrowth and elaboration of dendritic trees are
regulated by conserved genetic programs as well as activity-dependent signaling (Jan
and Jan, 2010). During this period, the dendritic tree is highly dynamic, regulated by
coordinated mechanisms involving transcription, translation, various signaling pathways,
cytoskeleton formation, and the organization of organelles (Jan and Jan, 2010). As the
animal reaches adulthood, the dendritic tree becomes a relatively stable structure with a
defined size and complexity (Koleske, 2013). Interestingly, recent work has revealed that
dendritic trees are also dynamically regulated in adulthood and shed light on the
underlying mechanisms (Lin and Koleske, 2010; Warren et al., 2012). In addition,
examples are emerging that show evidence of altered dendritic stability in disease
models (Lin and Koleske, 2010), supporting the importance of the regulation of neuronal
morphology in adulthood for proper brain function.
Cyclin-dependent kinase-like 5 (CDKL5) is a protein highly conserved in
mammals, showing enriched expression in various cell populations of the brain, most
prominently in the pyramidal neurons of the cortex and hippocampus (Zeisel et al.,
2015). Interestingly, the expression of CDKL5 is also temporally regulated, showing
significant upregulation in the first few postnatal weeks (Hector et al., 2016; Ricciardi et
al., 2012; Zhu et al., 2013), mirroring the timeline of primary dendritic outgrowth and
excitatory synaptogenesis at pyramidal neurons. Consistent with these findings, CDKL5deficient mice have been found to have reduced dendritic complexity across various
excitatory neuron populations (Amendola et al., 2014; Fuchs et al., 2014; Tang et al.,
2017). For example, hippocampal CA1 neurons in Cdkl5 knockout and conditional
knockout mice show reduced dendritic complexity in adulthood (Amendola et al., 2014;
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Tang et al., 2017). However, no study to date has examined neuronal morphology in
CDKL5-deficient mice across development, and therefore it remains unknown whether
the dendritic arborization phenotype is due to a defect in outgrowth, maintenance, or
both. Interestingly, evidence suggests that CDKL5 protein levels remains elevated
throughout adulthood, suggesting a role in the maintenance of neuronal structure and
function.
Here, we investigate the morphology of hippocampal CA1 pyramidal neurons, in
vivo and across development, in a mouse model of CDKL5 deficiency disorder (CDD).
We find that both dendritic complexity and spine density are unaltered in juvenile
CDKL5-deficient mice. In contrast, CDKL5-deficient mice show a robust reduction in
dendritic complexity in adulthood, with no significant changes in spine density.
Comparing dendritic morphology across development, we observe that CDKL5-deficient
mice fail to show the continued elaboration of the dendritic tree in adulthood that is
apparent in wild type mice. Taken together, our results suggest a novel role for CDKL5
in the regulation of elaboration of the dendritic tree during adulthood and highlight the
importance of dendritic stability in a model of CDD.

Results
Reduced dendritic complexity in CDKL5-deficient mice in adulthood
To investigate neuronal morphology in vivo, we generated wild type and CDKL5deficient (R59X, see Chapter 3) mice carrying the Thy1-GFP (line M) transgenic reporter
allele (Feng et al., 2000). Previous work suggests that in mice, dendritic tree formation
and patterning are highly dynamic processes prior to postnatal day (P) 21, with
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subsequent stabilization of the dendritic tree throughout adulthood (Koleske, 2013).
Therefore, we examined dendritic complexity in pyramidal neurons of the hippocampal
CA1 region at two different developmental time points, postnatal day (P) 21 and P140,
corresponding approximately to juvenile and adult stages of mouse development.
In adult (P140) R59X mice, we discovered that CA1 pyramidal neurons exhibited
significantly reduced dendritic branching at both the basal and proximal apical dendritic
trees (Fig. 1A, C). In addition, total apical dendritic length was also significantly reduced
(Fig. 1B, D). In contrast, in juvenile (P21) R59X mice, Sholl analysis did not reveal any
significant differences compared to wild type littermates and total dendritic lengths of
both apical and basal trees were unaltered in R59X mice (Fig. 2). These results suggest
that a dendritic branching deficit in R59X mice emerges postnatally in a delayed manner,
after the first three weeks of postnatal development.

Loss of CDKL5 limits dendritic arborization in adulthood
The emergence of a dendritic arborization deficit in adult CDKL5-deficient mice
can be due to 1) an impairment in continued dendritic outgrowth and/or 2) impaired
stability that leads dendritic retraction. To gain insight into these two potential underlying
mechanisms, we compared the dendritic complexity of hippocampal CA1 neurons in wild
type and R59X mice at both P21 and P140 time points (Fig. 3). Interestingly, we found
that CA1 pyramidal neurons in wild type mice show continued elaboration of the
dendritic tree from P21 to P140, particularly at the proximal apical tree, leading to an
increase in dendritic complexity (Fig. 3A, C) as well as an increase in overall dendritic
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length (Fig. 3B, D). In contrast, R59X mice failed to show an enhancement of either
dendritic complexity or overall dendritic length from P21 to P140 (Fig. 3A-D).

Unaltered dendritic spine density in CDKL5-deficient mice
The alteration in dendritic complexity in R59X mice suggests that CDKL5 may
play a critical role in the development and maintenance of neuronal morphology in
adulthood. We additionally examined dendritic spine density at CA1 pyramidal neurons
at the same developmental time points in R59X and wild type littermate mice. No
significant changes in dendritic spine density were found in either the proximal apical,
distal apical, or basal dendritic trees of CA1 pyramidal neurons (Fig. 4A-F). These
results suggest that the dendritic arborization deficit in R59X mice is not accompanied by
a change in spine density at either the juvenile or adult developmental stages. Further
work, however, is necessary to characterize the morphologic parameters of dendritic
spines in wild type and R59X mice.

Discussion
The elaboration of the dendritic tree of neurons relies upon an intricate genetic
program as well as activity-dependent cues throughout development (Jan and Jan,
2010). Furthermore, the patterning and stability of the dendritic tree can be modulated
throughout adulthood (Koleske, 2013). The finding that dendritic complexity is reduced
specifically in R59X mice in adulthood suggests that CDKL5 may specifically regulate or
maintain aspects of postnatal dendritic patterning and stability. Furthermore, in
comparing juvenile and adult mice, we find that R59X mice fail to show a continued
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elaboration of the dendritic tree in adulthood that is apparent in wild type controls. Taken
together, our results suggest that CDKL5 plays a critical role in the outgrowth, branching,
and/or stability of the dendritic tree during adulthood.
We previously discovered that mice lacking CDKL5 selectively in forebrain
glutamatergic neurons (Nex-cKO) recapitulate the dendritic branching deficits at the
proximal apical and basal dendritic trees of CA1 pyramidal neurons (Tang et al., 2017).
This result suggests that CDKL5 regulates dendritic complexity in a glutamatergic
neuron-autonomous manner. However, due to the widespread expression of Nex-Cre
throughout the forebrain, sustained changes in neuronal network activity during
postnatal development, as well as cell-autonomous mechanisms, can both contribute to
the dendritic complexity deficit in Nex-cKO mice.
Dendritic spines represent the primary sites of excitatory synapses formed onto
pyramidal neurons, and their density and morphology can yield information regarding the
number and distribution of synapses (Nimchinsky et al., 2002). Dendritic spine pathology
is a common finding across mouse models of neurodevelopmental disorders and even in
human patients (Penzes et al., 2011). Our results show that juvenile and adult R59X
mice do not exhibit significant changes in dendritic spine density at CA1 pyramidal
neurons. This result stands in contrast to our previous findings in Nex-cKO mice, which
exhibited increased spine density (Tang et al., 2017). Further investigation is necessary
to determine whether spine morphology is altered R59X mice at different points in
development, which could reflect an underlying change in excitatory synaptic function. In
addition, although our studies are thus far limited to hippocampal CA1 pyramidal
neurons, CDKL5 is known to also be expressed in cortical regions (Wang et al., 2012).
Given that distinct mechanisms may regulate cortical and hippocampal pyramidal neuron
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morphology (Attardo et al., 2015), future studies should investigate the possibility the
CDKL5 regulates morphology in a brain region-specific manner.
In order to determine the extent to which CDKL5 regulates neuronal morphology
in a cell-autonomous manner, an approach that achieves sparse knockout of CDKL5 in
vivo is necessary. We are currently generating mice carrying the Slick-V transgenic
allele (Young et al., 2008) and a conditional Cdkl5 knockout allele, which will allow
temporally-inducible, sparse knockout of CDKL5 in various brain regions. Together with
our previous findings in R59X and Nex-cKO mice, the studies in Slick-V conditional
knockout mice will allow us to differentiate the pyramidal neuron-autonomous and
network activity-dependent effects of CDKL5 loss on neuronal morphology. Additionally,
by inducing Cre activity at distinct time points during development, we can further dissect
the roles of CDKL5 in early and late postnatal development.

Materials and Methods
Wild type and R59X littermate mice carrying Thy1-GFP (genotypes: R59X/y;
Thy1-GFP and +/y; Thy1-GFP) at the ages of P21 and P140 were used for neuronal
morphology experiments. The methods used in this chapter are identical to those used
to investigate neuronal morphology in Nex-cKO mice (Chapter 2). Additionally, we thank
Dr. Mollie Meffert and her lab at the Johns Hopkins School of Medicine for sharing the
Slick-V transgenic mouse line (Young et al., 2008) with us.
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Figures

Figure 1. Reduced dendritic complexity of hippocampal CA1 pyramidal neurons in
adult CDKL5 R59X mice.
(A) Reduced complexity of the basal dendritic tree in R59X mice. (B) Total basal
dendrite length was not significantly altered. (C) Reduced complexity of the proximal
apical dendritic tree in R59X mice. (D) Total apical dendrite length was also significantly
reduced in R59X mice (n=18 cells/3 mice, wild type; n=21 cells/3 mice, R59X)
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Figure 2. Unaltered dendritic complexity of hippocampal CA1 pyramidal neurons
in juvenile CDKL5 R59X mice.
(A-B) Unaltered complexity and total length of the basal dendritic tree in R59X mice
(n=11 cells/5 mice, wild type; n=18 cells/5 mice, R59X). (C-D) Unaltered complexity and
total length of the apical dendritic tree in R59X mice (n=19 cells/7 mice, wild type; n=14
cells/3 mice, R59X)
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Figure 3. Loss of CDKL5 limits dendritic arborization in adulthood.
(A, C) Comparison of the Sholl analyses of the basal and apical trees of CA1 pyramidal
neurons across development in WT and R59X mice. Note the continued increase in
dendritic complexity of WT mice from P21 to P140, evident by the increase in number of
intersections, and the lack of this increase in R59X mice. (B, D) Comparison of total
dendrite length of the basal and apical trees of CA1 pyramidal neurons across
development in WT and R59X mice. Note the significant increase in apical dendritic
length in WT mice from P21 to P140 and the lack of this increase in R59X mice.
Respective sample sizes are indicated in the figure legend.
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Figure 4. Unaltered spine density of hippocampal CA1 pyramidal neurons in
juvenile and adult CDKL5 R59X mice.
(A-C) Unaltered density of dendritic spines in juvenile (P21) R59X mice. (D-F) Unaltered
density of dendritic spines in adult (P14) R59X mice. Respective sample sizes are
indicated in each figure.
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CHAPTER 5 – EXTENDED DISCUSSION AND FUTURE DIRECTIONS

Cellular Origins of CDKL5 Deficiency Disorder-Related Phenotypes
The findings presented in this dissertation show that most of the behavioral
phenotypes in Cdkl5 constitutive knockout (KO) mice “segregate” in Cdkl5 conditional
knockout (cKO) mice, such that impaired learning and memory is selectively
recapitulated in Nex-cKO mice and autistic-like features are selectively recapitulated in
Dlx-cKO mice. These results suggest that CDKL5 function in each of these forebrain
neuronal populations is necessary for the development of proper learning and memory
and social behaviors, respectively. Interestingly, several important phenotypes of KO
mice are not recapitulated in either Nex-cKO and Dlx-cKO mice; these include
alterations in anxiety-related behavior, locomotion, and motor coordination. These
phenotypes may depend on the loss of CDKL5 in cell types and brain regions not
covered by either the Nex-Cre and Dlx5/6-Cre drivers alone. Moreover, future studies
can conduct a side-by-side comparison of Nex-cKO, Dlx-cKO, and KO mice. This would
allow a side-by-side comparison of phenotypic severity across these mouse lines, which
may reveal subtle differences. Furthermore, CDKL5 may function in both populations, in
a synergistic manner, to regulate aspects of learning and memory, social behavior, and
stereotypic behavior.

Epilepsy in CDKL5 Deficiency Disorder
Early-onset, treatment-refractory epilepsy is a central feature of CDKL5
deficiency disorder (CDD) in humans. However, spontaneous seizures have not been
observed in Cdkl5 KO and cKO mice despite EEG studies at multiple ages conducted by
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multiple laboratories. Nonetheless, these results do not rule out the possibility that Cdkl5
KO and cKO mice have subclinical epilepsy, particularly at extreme ends of the age
spectrum (infancy/juvenile period and old age) when EEG monitoring and other studies
may not be feasible or practical. Furthermore, whereas human CDKL5-deficient patients
nearly universally exhibit epilepsy, a lower prevalence in mice may preclude detection
without large-scale studies.
Various chemoconvulsants and seizure induction paradigms have been used to
attempt to assess seizure threshold in Cdkl5 KO and cKO mice. In this regard, there are
a few promising results, including the enhanced susceptibility of KO mice to the
ionotropic glutamate receptor agonist N-methyl-D-aspartate (NMDA). However, other
seizure paradigms have not consistently revealed a reduction in seizure threshold. At
least in mice, it appears that there may be distinct pro-epileptic and anti-epileptic
mechanisms underlying CDD. This finding is corroborated at the synaptic, circuit, and
network levels, where there are both results suggesting hyper-excitability and hypoexcitability. Therefore, it may be appropriate to consider additional hypotheses about the
mechanisms underlying epilepsy in CDD. For example, depolarizing inhibition and
network hyper-synchrony are alternative, pro-epileptic mechanisms that may enhance
excitatory drive in mouse models of CDD.

Phenotypic Heterogeneity in CDKL5 Deficiency Disorder
There is significant phenotypic heterogeneity in human CDD. Much of this has
been attributed to variable X-chromosome inactivation in female patients, who are
heterozygous for mutations in CDKL5. Surprisingly, significant phenotypic variability is
present even in genetically inbred, male hemizygous mice carrying Cdkl5 mutations.
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Although phenotypic variability in Cdkl5 KO mice has not been quantitatively analyzed, it
has raised the possibility that there are multiple developmental trajectories associated
with CDD leading to distinct phenotypic outcomes. In addition to the specific pattern of
CDKL5 loss, these trajectories may depend on genetic background, parental, prenatal,
or perinatal factors, and they may additionally be modulated by environment throughout
postnatal life. Our studies in mice have revealed different disease mechanisms that
contribute to distinct phenotypes in CDD, expanding the opportunities for mechanismbased therapeutic development for CDD patients.

CDKL5 Deficiency Disorder and Interspecies Differences
To date, mice have been the primary animal models used for investigation of the
mechanisms underlying CDD. In addition to confirming the genetic etiology of CDD,
mouse models have offered important insights into how CDKL5 impacts neuronal
morphology, synaptic transmission, circuit architecture, and network activity. The
translational value of these findings is supported by the high degree of conservation in
primary sequence of the CDKL5 protein between mice and humans, as well as the
similarities in many of the classic cell types and both local and long-range circuit
architecture in the brain (Miller et al., 2014; Oh et al., 2014). In this respect, mice will
continue to provide key insights into the pathogenic mechanisms underlying CDD.
There are, however, also significant differences between human and mouse
brains that may account for the absence of key features in mouse models of CDD, such
as epilepsy. CDKL5 expression is enriched in forebrain regions, most prominently in
cortical glutamatergic neurons and GABAergic interneurons. Given that the cortex is also
the most highly evolved region of the human brain and thought to account for many of
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the unique behaviors and capabilities of the human species (Sousa et al., 2017), it is
perhaps not surprising that network-level phenotypes such as epilepsy are not
recapitulated in mice, which unlike humans are a lissencephalic species. Furthermore,
significant differences exist between the transcriptional landscapes of the human and
mouse brains during development, leading to differences in cell migration, laminar
organization, myelination, synaptogenesis, and adult neurogenesis (Silbereis et al.,
2016). Despite these differences, CDKL5 likely plays conserved roles in the regulation of
synaptic and circuit function in many brain regions in humans and mice. Therefore,
investigations into how CDKL5 modulates circuit excitability and plasticity will likely yield
important insights into the mechanisms that generate epilepsy, impaired cognition, and
other neurologic deficits in CDD, uncovering novel therapeutic avenues for the treatment
of CDD.
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